	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)	CLUSTER	PREPROCESSED_SENTENCE
S59-PMC3075531	PMC3075531	7/2010	S59-PMC3075531	['one option WOULD BE a national or multinational study based on randomization of school districts or other suitable units in regions of low sunlight intensity, PERHAPS including multiple outcomes that MIGHT be AFFECTED by Vitamin D, such as diabetes, obesity, Respiratory infections, and asthma.4546ALTERNATIVELY, high-risk first-degree relatives of individu-als with ms COULD BE targeted in a smaller trial,47ALTHOUGH randomization and compliance COULD BE more CHALLENGING.']	[('FUTURE_WORK', 11), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('FUTURE_WORK', 370), ('ANOMALY_CURIOUS_FINDING', 409), ('FUTURE_WORK', 447), ('DIFFICULT_TASK', 461)]	9	[('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 259, 'respiratory')]	0	['one option national multinational randomization school districts units regions sunlight intensity, outcomes diabetes, obesity,  infections, asthma.4546alternatively, first-degree relatives individu-als ms trial,47although randomization challenging.']
S64-PMC3277098	PMC3277098	12/2011	S64-PMC3277098	['they PROPOSED that, as reduced Lung volume is a RISK FACTOR for Lung function and Respiratory illness in Humans, Vitamin D deficiency COULD increase the risk of these conditions through EFFECTS on Lung Tissue growth.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 134), ('SUPERFICIAL_RELATIONSHIP', 186)]	4	[('UBERON_0002048', 'lung', 31, 'lung'), ('UBERON_0002048', 'lung', 64, 'lung'), ('UBERON_0001004', 'respiratory system', 82, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 105, 'humans'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0002048', 'lung', 197, 'lung'), ('UBERON_0000479', 'tissue', 202, 'tissue')]	0	['that, lung volume lung  illness humans,  increase conditions lung tissue growth.']
S154-PMC3347028	PMC3347028	3/2012	S154-PMC3347028	['beyond growth, RECENT REPORTS of neonates followed prospectively for acute Viral infections and bronchiolitis from Respiratory syncytial Virus (Rsv) SUPPORT the PREMISE that these states of deficiency do IMPACT on the health of the young infant and SUGGEST a greater ROLE of Vitamin D beyond bone health [103,104,105].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 161), ('SUPERFICIAL_RELATIONSHIP', 204), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 267)]	7	[('NCBITaxon_1', 'root', 75, 'viral'), ('UBERON_0001004', 'respiratory system', 115, 'respiratory'), ('NCBITaxon_1', 'root', 137, 'virus'), ('NCBITaxon_10088', 'Mus <genus>', 144, 'RSV'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]	0	['beyond growth, neonates followed acute viral infections bronchiolitis  syncytial virus (rsv) young infant  bone [103,104,105].']
S16-PMC3348565	PMC3348565	4/2012	S16-PMC3348565	['our systematic review identified one randomised placebo controlled trial3RELATING pneumonia or Lower Respiratory infections to Vitamin D deficiency supplementation in young children.']	[('SUPERFICIAL_RELATIONSHIP', 73)]	1	[('UBERON_0009567', 'nail of pedal digit', 95, 'lower'), ('UBERON_0001004', 'respiratory system', 101, 'respiratory'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]	0	['randomised placebo trial3relating pneumonia  infections  supplementation young children.']
S258-PMC3407995	PMC3407995	7/2012	S258-PMC3407995	['a recent review of studies LINKING maternal Vitamin D status during Pregnancy with maternal, foetal and Postnatal outcomes SUPPORTS a ROLE of maternal Vitamin D status, PARTICULARLY early in Pregnancy, in Modulating the risk of Pregnancy complications and in sustaining foetal growth, body composition, Skeletal Development, Immune Maturation and Respiratory health [141].']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 134), ('IMPORTANT_CONSIDERATION', 169)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0007567', 'parturition', 104, 'postnatal'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'pregnancy'), ('GO_0065007', 'biological regulation', 205, 'modulating'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0001501', 'skeletal system development', 303, 'skeletal development'), ('UBERON_0004288', 'skeleton', 303, 'skeletal'), ('GO_0050900', 'leukocyte migration', 325, 'immune maturation'), ('UBERON_0002405', 'immune system', 325, 'immune'), ('UBERON_0001004', 'respiratory system', 347, 'respiratory')]	0	['maternal  status pregnancy maternal, foetal postnatal outcomes maternal  status, pregnancy, pregnancy sustaining foetal growth, composition, skeletal development, immune maturation  [141].']
S66-PMC3417531	PMC3417531	7/2012	S66-PMC3417531	"['[""""(91)childreninfectious diseasehigh rate of simkania negevensis among canadian inuit infants hospitalized with Lower Respiratory Tract infections (92)childrennutritioniron deficiency and anaemia prevalence and ASSOCIATED etiologic RISK FACTORS in first nations and inuit communities in northern ontario and nunavut (93)childrennutritionfood insecurity among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (59)childrennutritionvitamin D status of inuit preschoolers reflects season and Vitamin D intake (56)childrenenvironment/environmental exposures; infectious diseaseeffect of Prenatal exposure to Polychlorinated Biphenyls on incidence of acute Respiratory infections in preschool inuit children (25)childrenchronic disease; interventions/programmingthe benefits of sound field amplification in classrooms of inuit students of nunavik: a pilot project (73)childrensocial DETERMINANTS of health; tobaccocultural, socioeconomic, and health indicators among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (9)childreninfectious disease; tobaccoindoor air quality and the risk of Lower Respiratory Tract infections in young canadian inuit children (41)childreninfectious disease; interventions/programmingheat recovery ventilators prevent Respiratory disorders in inuit children (40)childrengenetics; nutritionadaptation of inuit children to a low-calcium diet (83)childreninfectious disease; health care, policy, Human resourcesbronchiolitis in inuit children from a canadian central arctic community, 1995–1996 (69)youthchronic diseasecauses and CONTRIBUTIONS to differences in Life expectancy for inuit nunangat and canada, 1994–2003 (82)youthinfectious diseaseotitis media and Hearing loss among 12–16 year-old inuit of inukjuak, quebec, canada (35)youthinjuryinjury mortality risk assessment and targeting the subpopulations for prevention in the northwest territories, canada (86)youthnutritionage differences in Vitamin A intake among canadian inuit (55)youthmental health and wellbeingcompleted suicides among the inuit of northern quebec, 1982–1996: a case-control study (77)youthmental health and wellbeing; social determinants of healthsuicidality in a sample of arctic households (76)youthinfectious disease; interventions/programminghiv testing experiences of aboriginal youth in canada: service IMPLICATIONS (74)youthinfections disease; social determinants of healthdeterminants of Sexually Transmitted infections among canadian inuit adolescent populations (30)youthinfections disease; mental health and wellbeingyouth sexual health in nunavut: a needs-based survey of knowledge, attitudes and behaviour (31)maternalbirth outcomesreclaiming Birth, health, and community: midwifery in the inuit villages of nunavik, canada (68)maternalenvironment/environmental exposuresorganochlorine levels in maternal and Umbilical Cord Blood Plasma in arctic canada (49)maternalenvironment/environmental exposuresexposure of the inuit population of nunavik (arctic quebec) to lead and mercury (48)maternalnutritiondietary assessment of indigenous canadian arctic women with a focus on Pregnancy and Lactation (54)maternalnutritioncontribution of selected traditional and market Foods to the diet of nunavik inuit women (57)maternalbirth outcomes; tobaccomaternal smoking at first Prenatal visit as a MARKER of risk for adverse Pregnancy outcomes in the qikiqtaaluk (baffin) region (8)maternalnutrition; environment/environmental exposuresfish Consumption and Blood Lipids in 3 ethnic groups of quebec (canada) (51)maternalhealth care, policy, Human resources; Birth outcomesconverging epistemologies: CRITICAL ISSUES in canadian inuit Childbirth and Pregnancy (65)maternalenvironment/environmental exposures; nutritiondeterminants of Polychlorinated Biphenyls and Methylmercury exposure in inuit women of Childbearing age (50)maternalhealth care, policy, Human resources; interventions/programmingthe outcome of Perinatal Care in inukjuak, nunavik, canada 1998–2002 (70)maternalhealth care, policy, Human resources; Birth outcomesthe inuulitsivik maternities: culturally appropriate midwifery and epistemological accommodation (66)maternalinfectious disease; interventions/programmingoncogenic human papillomavirus infection and Cervical lesions in aboriginal women in nunavut, canada (94)maternalchronic disease; social determinants of health; tobacco; mental health and Wellbeingthe health of cree, inuit and southern quebec women: similarities and differences (79)maternalnutrition; social DETERMINANTS of health; environment/environmental exposuresfood insecurity among inuit women exacerbated by socioeconomic stresses and climate change (60)children; youthchronic diseasethe RELATIONSHIP between socio-economic and geographic factors and asthma among canada\'s aboriginal populations (81)children; youthinfectious diseasehospitalization due to pneumonia among innu, inuit and non-aboriginal communities, newfoundland and labrador, canada (24)children; maternalbirth outcomesheart defects and other malformations in the inuit in canada: a baseline study (62)children; maternalbirth outcomesbirth outcomes in the inuit-inhabited areas of canada (95)children; maternalbirth outcomesdegree of rural isolation and Birth outcomes (63)children; maternalbirth outcomesrisks of adverse Pregnancy outcomes among inuit and north american indian women in quebec, 1985–97 (64)children; maternalenvironment/environmental exposuresprenatal exposure to Methylmercury and Pcbs AFFECTS distinct stages of information processing: an event-related POTENTIAL study with inuit children (44)children; maternalenvironment/environmental exposuresthe RELATION of lead neurotoxicity to the event-related potential p3b component in inuit children from arctic quebec (47)children; maternalenvironment/environmental exposuresthyroid hormone levels of Pregnant inuit women and their infants exposed to environmental contaminants (96)children; maternalenvironment/environmental exposuresneuromotor functions in inuit preschool children exposed to Pb, Pcbs, and hg (43)children; maternalenvironment/environmental exposuresbeneficial EFFECTS of a polyunsaturated Fatty Acid on infant development: EVIDENCE from the inuit of arctic quebec (52)children; maternalenvironment/environmental exposuresthe RELATION of environmental contaminants exposure to behavioural indicators in inuit preschoolers in arctic quebec (46)children; maternalinfectious diseaseneonatal Vitamin A deficiency and its IMPACT on acute Respiratory infections among preschool inuit children (33)children; maternalnutritionanaemia and iron status in inuit infants from northern quebec (97)children; maternalbirth outcomes; nutritioncongenital Heart defects in canadian inuit: is more Folic Acid making a difference?""""]']"	[('SUPERFICIAL_RELATIONSHIP', 209), ('SUPERFICIAL_RELATIONSHIP', 230), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1581), ('IMPORTANT_CONSIDERATION', 2342), ('SUPERFICIAL_RELATIONSHIP', 3334), ('IMPORTANT_CONSIDERATION', 3635), ('IMPORTANT_CONSIDERATION', 3644), ('SUPERFICIAL_RELATIONSHIP', 4527), ('SUPERFICIAL_RELATIONSHIP', 4715), ('SUPERFICIAL_RELATIONSHIP', 5499), ('INCOMPLETE_EVIDENCE', 5567), ('SUPERFICIAL_RELATIONSHIP', 5664), ('SUPERFICIAL_RELATIONSHIP', 6139), ('INCOMPLETE_EVIDENCE', 6202), ('SUPERFICIAL_RELATIONSHIP', 6304), ('SUPERFICIAL_RELATIONSHIP', 6495), ('EXPLICIT_QUESTION', 6787)]	18	[('UBERON_0004905', 'articulation', 110, 'lower respiratory tract'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 451, 'D'), ('CHEBI_27300', 'vitamin D', 502, 'vitamin D'), ('GO_0007565', 'female pregnancy', 596, 'prenatal'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 617, 'polychlorinated biphenyls'), ('UBERON_0001004', 'respiratory system', 665, 'respiratory'), ('UBERON_0004905', 'articulation', 1113, 'lower respiratory tract'), ('UBERON_0001004', 'respiratory system', 1272, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 1447, 'human'), ('UBERON_0000104', 'life cycle', 1613, 'life'), ('GO_0007605', 'sensory perception of sound', 1714, 'hearing'), ('CHEBI_27300', 'vitamin D', 1952, 'vitamin A'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 2429, 'sexually transmitted'), ('GO_0007567', 'parturition', 2689, 'birth'), ('UBERON_0002331', 'umbilical cord', 2855, 'umbilical cord'), ('UBERON_0000178', 'blood', 2870, 'blood'), ('UBERON_0001969', 'blood plasma', 2876, 'plasma'), ('GO_0007565', 'female pregnancy', 3119, 'pregnancy'), ('GO_0007595', 'lactation', 3133, 'lactation'), ('CHEBI_33290', 'food', 3212, 'foods'), ('GO_0007565', 'female pregnancy', 3314, 'prenatal'), ('GO_0007565', 'female pregnancy', 3361, 'pregnancy'), ('GO_0007631', 'feeding behavior', 3477, 'consumption'), ('UBERON_0000178', 'blood', 3493, 'blood'), ('CHEBI_18059', 'lipid', 3499, 'lipids'), ('NCBITaxon_9606', 'Homo sapiens', 3577, 'human'), ('GO_0007567', 'parturition', 3594, 'birth'), ('GO_0007623', 'circadian rhythm', 3669, 'childbirth'), ('GO_0007565', 'female pregnancy', 3684, 'pregnancy'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 3768, 'polychlorinated biphenyls'), ('CHEBI_33963', 'metallocene', 3798, 'methylmercury'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 3839, 'childbearing'), ('NCBITaxon_9606', 'Homo sapiens', 3889, 'human'), ('GO_0036356', 'cyclic 2,3-diphosphoglycerate synthetase activity', 3946, 'perinatal care'), ('UBERON_0012101', 'perinatal stage', 3946, 'perinatal'), ('NCBITaxon_9606', 'Homo sapiens', 4033, 'human'), ('GO_0007567', 'parturition', 4050, 'birth'), ('UBERON_0005434', 'cervical region', 4263, 'cervical'), ('GO_0035706', 'T-helper 1 cell chemotaxis', 4406, 'wellbeingThe'), ('GO_0007567', 'parturition', 5248, 'birth'), ('GO_0007565', 'female pregnancy', 5316, 'pregnancy'), ('CHEBI_33963', 'metallocene', 5476, 'methylmercury'), ('CHEBI_26199', 'polyprenol', 5494, 'PCBs'), ('GO_0007565', 'female pregnancy', 5860, 'pregnant'), ('CHEBI_37983', 'sulfur-35 atom', 6054, 'Pb'), ('CHEBI_26199', 'polyprenol', 6058, 'PCBs'), ('CHEBI_35366', 'fatty acid', 6168, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 6466, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 6511, 'respiratory'), ('UBERON_0000948', 'heart', 6716, 'heart'), ('CHEBI_30751', 'formic acid', 6757, 'folic acid')]	0	"['[""""(91)childreninfectious diseasehigh rate simkania negevensis among canadian inuit infants hospitalized respiratory tract infections (92)childrennutritioniron anaemia etiologic nations inuit communities northern ontario nunavut (93)childrennutritionfood among inuit preschoolers: nunavut inuit child survey, 2007–2008 (59)childrennutritionvitamin status inuit preschoolers season intake (56)childrenenvironment/environmental exposures; infectious diseaseeffect prenatal exposure polychlorinated biphenyls acuory infections preschool inuit children (25)childrenchronic disease; interventions/programmingthe amplification classrooms inuit students nunavik: (73)childrensocial health; tobaccocultural, socioeconomic, among inuit preschoolers: nunavut inuit child survey, 2007–2008 (9)childreninfectious disease; tobaccoindoor air respiratory tract infections young canadian inuit children (41)childreninfectious disease; interventions/programmingheat recovery ventilators preveory disorders inuit children (40)childrengenetics; nutritionadaptation inuit children low-calcium diet (83)childreninfectious disease; care, policy, human resourcesbronchiolitis inuit children canadian central arctic community, 1995–1996 (69)youthchronic diseasecauses life expectancy inuit nunangat canada, 1994–2003 (82)youthinfectious diseaseotitis media hearing loss among 12–16 year-old inuit inukjuak, quebec, canada (35)youthinjuryinjury mortality subpopulations northwest territories, canada (86)youthnutritionage n intake among canadian inuit (55)youthmental wellbeingcompleted suicides among inuit northern quebec, 1982–1996: case-control (77)youthmental wellbeing; social healthsuicidality sample arctic households (76)youthinfectious disease; interventions/programminghiv testing experiences aboriginal youth canada: service (74)youthinfections disease; social healthdeterminants sexually transmitted infections among canadian inuit adolescent populations (30)youthinfections disease; mental wellbeingyouth sexual nunavut: needs-based survey knowledge, attitudes behaviour (31)maternalbirth outcomesreclaiming birth, health, community: midwifery inuit villages nunavik, canada (68)maternalenvironment/environmental exposuresorganochlorine levels maternal umbilical cord blood plasma arctic canada (49)maternalenvironment/environmental exposuresexposure inuit population nunavik (arctic quebec) mercury (48)maternalnutritiondietary indigenous canadian arctic women pregnancy lactation (54)maternalnutritioncontribution selected market foods diet nunavik inuit women (57)maternalbirth outcomes; tobaccomaternal smoking prenatal visit pregnancy outcomes qikiqtaaluk (baffin) region (8)maternalnutrition; environment/environmental exposuresfish consumption blood lipids 3 ethnic quebec (canada) (51)maternalhealth care, policy, human resources; birth outcomesconverging epistemologies: canadian inuit childbirth pregnancy (65)maternalenvironment/environmental exposures; nutritiondeterminants polychlorinated biphenyls methylmercury exposure inuit women childbearing age (50)maternalhealth care, policy, human resources; interventions/programmingthe outcome perinatal inukjuak, nunavik, canada 1998–2002 (70)maternalhealth care, policy, human resources; birth outcomesthe inuulitsivik maternities: culturally midwifery epistemological accommodation (66)maternalinfectious disease; interventions/programmingoncogenic human papillomavirus infection cervical lesions aboriginal women nunavut, canada (94)maternalchronic disease; social health; tobacco; mental wellbeingthe cree, inuit southern quebec women: (79)maternalnutrition; social health; environment/environmental exposuresfood among inuit women exacerbated socioeconomic climate (60)children; youthchronic diseasethe socio-economic geographic asthma among canada*s aboriginal populations (81)children; youthinfectious diseasehospitalization pneumonia among innu, inuit non-aboriginal communities, newfoundland labrador, canada (24)children; maternalbirth outcomesheart defects malformations inuit canada: baseline (62)children; maternalbirth outcomesbirth outcomes inuit-inhabited canada (95)children; maternalbirth outcomesdegree rural isolation birth outcomes (63)children; maternalbirth outcomesrisks pregnancy outcomes among inuit north american indian women quebec, 1985–97 (64)children; maternalenvironment/environmental exposuresprenatal exposure methylmercury pcbs stages processing: event-related inuit children (44)children; maternalenvironment/environmental exposuresthe neurotoxicity event-related p3b inuit children arctic quebec (47)children; maternalenvironment/environmental exposuresthyroid hormone levels pregnant inuit women infants exposed environmental (96)children; maternalenvironment/environmental exposuresneuromotor functions inuit preschool children exposed pb, pcbs, hg (43)children; maternalenvironment/environmental exposuresbeneficial polyunsaturated fatty acid infant development: inuit arctic quebec (52)children; maternalenvironment/environmental exposuresthe environmental exposure behavioural inuit preschoolers arctic quebec (46)children; maternalinfectious diseaseneonatn acuory infections among preschool inuit children (33)children; maternalnutritionanaemia iron status inuit infants northern quebec (97)children; maternalbirth outcomes; nutritioncongenital defects canadian inuit: folic acid difference?""""]']"
S3-PMC3427192	PMC3427192	4/2012	S3-PMC3427192	['additionally, a GROWING body of LITERATURE SUGGESTS that there is a RELATIONSHIP between Vitamin D status and Respiratory symptoms, PRESUMABLY through immunomodulatory EFFECTS of Vitamin D. this review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on Human studies.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 132), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 228), ('QUESTION_ANSWERED_BY_THIS_WORK', 278)]	8	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 110, 'respiratory'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 287, 'human')]	0	['additionally,  status  symptoms, immunomodulatory . discusses  asthma age spectrum, human studies.']
S9-PMC3427192	PMC3427192	4/2012	S9-PMC3427192	['indeed, numerous dietary hypotheses HAVE BEEN PROPOSED.13-15among the Nutrients and antioxidants included in this HYPOTHESIS, Vitamin D is of particular INTEREST SINCE Vitamin D concentrations decrease with increased time spent indoors, decreased exposure to sunlight, less exercise, obesity, and inadequate Calcium intake.16additionally, a GROWING BODY of literature SUGGESTS that there is a RELATIONSHIP between Vitamin D status and asthma-RELATED Respiratory symptoms,17-22PRESUMABLY through the immunomodulatory EFFECTS of Vitamin D.23,24this brief review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on EMERGING Human STUDIES over the past decade.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 114), ('ANOMALY_CURIOUS_FINDING', 153), ('PROBABLE_UNDERSTANDING', 162), ('INCOMPLETE_EVIDENCE', 341), ('INCOMPLETE_EVIDENCE', 368), ('SUPERFICIAL_RELATIONSHIP', 393), ('SUPERFICIAL_RELATIONSHIP', 442), ('ANOMALY_CURIOUS_FINDING', 474), ('SUPERFICIAL_RELATIONSHIP', 516), ('SUPERFICIAL_RELATIONSHIP', 586), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 645)]	14	[('CHEBI_33284', 'nutrient', 70, 'nutrients'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 308, 'calcium'), ('CHEBI_27300', 'vitamin D', 414, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 450, 'respiratory'), ('CHEBI_27300', 'vitamin D', 527, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 570, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 654, 'human')]	0	['indeed, dietary proposed.13-15among nutrients antioxidants hypothesis,   concentrations decrease spent indoors, decreased exposure sunlight, exercise, obesity, calcium intake.16additionally,  status asthma-related  symptoms,17-22presumably immunomodulatory .23,24this discusses  asthma age spectrum, decade.']
S15-PMC3427192	PMC3427192	4/2012	S15-PMC3427192	['vdrs are Expressed on a variety of Airway Immune Cells, where they function as classic Nuclear Steroid Hormone receptors and ultimately Regulate the transcription of numerous Genes associated with inflammation and Immunomodulation.27vitamin d also plays an IMPORTANT ROLE in Respiratory infection by facilitating Toll-Like Receptor Signaling through increased Synthesis of Human Cathelicidin Antimicrobial peptide,28-30which is cleaved to generate the active Cationic peptide, Ll-37.31,32vitamin D also exerts direct EFFECTS on target cells independent of Gene transcription33and MAY THEREFORE be of relevance to Airway inflammatory disorders.34while Vitamin D can suppress il-1735and Il-4-mediated Expression of Il-13,35,36it CAN also shift the th1/th2 balance toward th2 dominance.37THESE CONTRADICTORY actions MAY BE DUE to the direct actions of Vitamin D on cd4+T Cells to promote an Il-10-secreting T-Regulatory population.38\n\nBiosynthesis Of Vitamin D\nBiosynthesis Of Vitamin D begins PRIMARILY with absorption of solar ultravoilet-b (uvb) radiation and secondarily via Consumption of Vitamin D-rich and fortified foods, such as oily fish, fortified grains and dairy products.26following exposure to uvb radiation, 7-Dehydrocholesterol within the skin is converted to Previtamin D3( fig.']	[('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267), ('SUPERFICIAL_RELATIONSHIP', 517), ('INCOMPLETE_EVIDENCE', 580), ('PROBABLE_UNDERSTANDING', 584), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 783), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 791), ('INCOMPLETE_EVIDENCE', 813), ('IMPORTANT_CONSIDERATION', 820), ('PROBABLE_UNDERSTANDING', 991)]	11	[('GO_0010467', 'gene expression', 9, 'expressed'), ('UBERON_0001005', 'respiratory airway', 35, 'airway'), ('CL_0000738', 'leukocyte', 42, 'immune cells'), ('UBERON_0002405', 'immune system', 42, 'immune'), ('GO_0005634', 'nucleus', 87, 'nuclear'), ('CHEBI_26764', 'steroid hormone', 95, 'steroid hormone'), ('GO_0065007', 'biological regulation', 136, 'regulate'), ('SO_0000704', 'gene', 175, 'genes'), ('GO_0050900', 'leukocyte migration', 214, 'immunomodulation'), ('UBERON_0001004', 'respiratory system', 275, 'respiratory'), ('GO_0002770', 'T cell inhibitory signaling pathway', 313, 'Toll-like receptor signaling'), ('GO_0009057', 'macromolecule catabolic process', 360, 'synthesis'), ('NCBITaxon_9606', 'Homo sapiens', 373, 'human'), ('PR_000006009', 'alpha-catulin', 379, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 392, 'antimicrobial'), ('CHEBI_36916', 'cation', 459, 'cationic'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 477, 'LL-37'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 496, 'D'), ('SO_0000704', 'gene', 556, 'gene'), ('UBERON_0001005', 'respiratory airway', 613, 'airway'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 685, 'IL-4'), ('GO_0010467', 'gene expression', 699, 'expression'), ('PR_000001470', 'interleukin-28B', 713, 'IL-13'), ('CHEBI_27300', 'vitamin D', 849, 'vitamin D'), ('CL_0000084', 'T cell', 866, 'T cells'), ('PR_000001470', 'interleukin-28B', 888, 'IL-10'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 904, 'T'), ('CL_0000232', 'erythrocyte', 906, 'regulatory'), ('GO_0065007', 'biological regulation', 906, 'regulatory'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 932, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 948, 'vitamin D'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 958, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 974, 'vitamin D'), ('GO_0007631', 'feeding behavior', 1076, 'consumption'), ('CHEBI_27300', 'vitamin D', 1091, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 1221, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 1274, 'previtamin D3')]	0	['vdrs expressed airway immune cells, nuclear steroid hormone receptors regulate transcription genes inflammation immunomodulation.27vitamin plays  infection facilitating toll-like receptor signaling synthesis human cathelicidin antimicrobial peptide,28-30which cleaved generate cationic peptide, ll-37.31,32vitamin exerts cells gene transcription33and airway inflammatory disorders.34while  suppress il-1735and il-4-mediated expression il-13,35,36it th1/th2 balance toward th2 dominance.37these actions  cd4+t cells il-10-secreting t-regulatory population.38\n\nbiosynthesis \nbiosynthesis  begins absorption solar ultravoilet-b (uvb) radiation secondarily via consumption -rich fortified foods, oily fish, fortified grains dairy products.26following exposure uvb radiation, 7-dehydrocholesterol skin converted previtamin d3( fig.']
S28-PMC3427192	PMC3427192	4/2012	S28-PMC3427192	['studies of Vitamin D exposure in early Life and Respiratory outcomesauthoryearcountrystudy designsample sizeage of children at assessmentdetermination of Vitamin D statusassociation between Vitamin D and Respiratory outcomesbelderbos572011netherlandsprospective cohort156 neonatesbirth to 1 ymaternal Food-frequency questionnaire and Cord Blood 25(Oh)Dlower 25(Oh)D concentrations ASSOCIATED with an increased risk of Respiratory syncytial Virus infectioncamargo582007united statesprospective cohort1194 mother-child dyads3 ymaternal Food-frequency questionnairehighest quartile of Vitamin D intake during Pregnancy ASSOCIATED with a lower risk of recurrent wheezingcamargo592011new zealandprospective cohort922 newbornsbirth to 5 ycord Blood 25(Oh)Dhigher 25(Oh)D ASSOCIATED with a decreased risk of Respiratory infection and wheezing BUT NO associations with childhood asthma NOTEDCARROLL602011CANADACROSS-sectional340 mother-infant dyads5–29 weeksmaternal whole Blood 25(Oh)Dincreasing maternal 25(Oh)D ASSOCIATED with decreased odds of asthma in mothers BUT no associations with infantile wheezing noteddevereux612007scotlandprospective cohort2000 Pregnant women, 1212 children5 ymaternal Food-frequency questionnairehighest and lowest maternal Vitamin D intakes ASSOCIATED with lower risk of wheezingerkkola622009finlandprospective cohort1669 mother-child dyads5 ymaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with lower risk of asthma and allergic rhinitisgale632008ukprospective cohort466 mothers and 178 children9 mo and 9 ymaternal Serum 25(Oh)Dmaternal Vitamin D levels > 75 nmol/l ASSOCIATED with increased risk of atopic dermatitis and asthmamiyake642010japanprospective cohort763 mother-child dyads16–24 momaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with a decreased risk of wheeze and atopic dermatitismorales652012spainprospective cohort1724 children12 mo, 4–6 ymaternal plasma 25(Oh)Dincreased maternal 25(Oh)D ASSOCIATED with a decreased risk of lower Respiratory infections BUT NOT wheezing or asthmarothers662011united statesprospective cohort219 childrenbirth to 5 ycord Blood 25(Oh)Dboth low and high Cord Blood 25(Oh)D ASSOCIATED with increased Aeroallergen sensitization BUT NOT with allergic rhinitis or asthma\nin other Birth cohort studies where 25(Oh)D concentrations were measured in the Plasma and whole Blood of Pregnant women, median 25(Oh)D concentrations ranged from APPROXIMATELY 20 to 29.5 ng/ml.60,63,65a 50% decrease in the odds of maternal asthma was FURTHER OBSERVED with every 35 nmol/l increase in 25(Oh)D levels, SUGGESTING a POSSIBLE LINK between Vitamin D status and asthma during Pregnancy.60HOWEVER, similar to the studies of maternal Vitamin D intake, NO CONSISTENT RELATIONSHIPS between 25(Oh)D concentrations and Respiratory symptoms during childhood HAVE BEEN observed.']	[('SUPERFICIAL_RELATIONSHIP', 381), ('SUPERFICIAL_RELATIONSHIP', 616), ('SUPERFICIAL_RELATIONSHIP', 765), ('ANOMALY_CURIOUS_FINDING', 836), ('ANOMALY_CURIOUS_FINDING', 878), ('SUPERFICIAL_RELATIONSHIP', 1006), ('ANOMALY_CURIOUS_FINDING', 1058), ('SUPERFICIAL_RELATIONSHIP', 1267), ('SUPERFICIAL_RELATIONSHIP', 1439), ('SUPERFICIAL_RELATIONSHIP', 1627), ('SUPERFICIAL_RELATIONSHIP', 1824), ('SUPERFICIAL_RELATIONSHIP', 1999), ('ANOMALY_CURIOUS_FINDING', 2064), ('SUPERFICIAL_RELATIONSHIP', 2213), ('ANOMALY_CURIOUS_FINDING', 2266), ('INCOMPLETE_EVIDENCE', 2471), ('INCOMPLETE_EVIDENCE', 2560), ('INCOMPLETE_EVIDENCE', 2568), ('INCOMPLETE_EVIDENCE', 2626), ('INCOMPLETE_EVIDENCE', 2639), ('SUPERFICIAL_RELATIONSHIP', 2648), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2706), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2770), ('SUPERFICIAL_RELATIONSHIP', 2784), ('INCOMPLETE_EVIDENCE', 2871)]	25	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 39, 'life'), ('UBERON_0001004', 'respiratory system', 48, 'respiratory'), ('CHEBI_28384', 'vitamin K', 154, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 204, 'respiratory'), ('CHEBI_33290', 'food', 301, 'food'), ('UBERON_0002240', 'spinal cord', 334, 'cord'), ('UBERON_0000178', 'blood', 339, 'blood'), ('CHEBI_78858', '(R)-2-methylpyrrolidine', 345, '25(OH)DLower'), ('CHEBI_71657', 'versiconol acetate', 358, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 418, 'respiratory'), ('NCBITaxon_1', 'root', 440, 'virus'), ('CHEBI_33290', 'food', 534, 'food'), ('CHEBI_27300', 'vitamin D', 582, 'vitamin D'), ('GO_0007565', 'female pregnancy', 606, 'pregnancy'), ('UBERON_0000178', 'blood', 737, 'blood'), ('CHEBI_72842', '9-oxo-ODE', 743, '25(OH)DHigher'), ('CHEBI_71657', 'versiconol acetate', 757, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 801, 'respiratory'), ('UBERON_0000178', 'blood', 965, 'blood'), ('CHEBI_74350', 'N-diazoacetylnorleucine methyl ester', 971, '25(OH)DIncreasing'), ('PR_000011614', 'opioid growth factor receptor', 974, 'OH'), ('PR_000006449', 'diacylglycerol kinase kappa', 977, 'DIncreasing'), ('CHEBI_71657', 'versiconol acetate', 998, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 998, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 1152, 'pregnant'), ('CHEBI_33290', 'food', 1193, 'food'), ('CHEBI_27300', 'vitamin D', 1249, 'vitamin D'), ('CHEBI_33290', 'food', 1378, 'food'), ('CHEBI_27300', 'vitamin D', 1422, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1576, 'serum'), ('CHEBI_51469', 'butyllithium', 1582, '25(OH)DMaternal'), ('CHEBI_27300', 'vitamin D', 1598, 'vitamin D'), ('CHEBI_33290', 'food', 1763, 'food'), ('CHEBI_27300', 'vitamin D', 1807, 'vitamin D'), ('CHEBI_86378', '(25R)-3beta-hydroxycholest-5-en-26-oic acid', 1965, '25(OH)DIncreased'), ('PR_000011040', 'nuclear receptor coactivator 1', 1967, '(OH'), ('CHEBI_71657', 'versiconol acetate', 1991, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1991, '25(OH ... D'), ('UBERON_0001004', 'respiratory system', 2041, 'respiratory'), ('UBERON_0000178', 'blood', 2163, 'blood'), ('CHEBI_73803', 'Ala-Asp', 2169, '25(OH)DBoth'), ('UBERON_0002240', 'spinal cord', 2194, 'cord'), ('UBERON_0000178', 'blood', 2199, 'blood'), ('CHEBI_71657', 'versiconol acetate', 2205, '25(OH)D'), ('CHEBI_2500', 'Aescin', 2239, 'aeroallergen'), ('GO_0007567', 'parturition', 2316, 'birth'), ('CHEBI_71657', 'versiconol acetate', 2343, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 2387, 'plasma'), ('UBERON_0000178', 'blood', 2404, 'blood'), ('GO_0007565', 'female pregnancy', 2413, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 2436, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 2610, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 2616, 'D'), ('CHEBI_27300', 'vitamin D', 2661, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2696, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 2752, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 2806, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 2833, 'respiratory')]	0	['studies  exposure life  outcomesauthoryearcountrystudy designsample sizeage children assessmentdetermination vitamin statusassociation   outcomesbelderbos572011netherlandsprospective cohort156 neonatesbirth ymaternal food-frequency questionnaire cord blood 25(oh)dlower 25(oh)d concentrations  syncytial virus infectioncamargo582007united statesprospective cohort1194 mother-child dyads3 ymaternal food-frequency questionnairehighest quartile  intake pregnancy recurrent wheezingcamargo592011new zealandprospective cohort922 newbornsbirth 5 ycord blood 25(oh)dhigher 25(oh)d decreased  infection wheezing childhood asthma notedcarroll602011canadacross-sectional340 mother-infant dyads5–29 weeksmaternal whole blood 25(oh)dincreasing maternal 25(oh)d decreased asthma mothers infantile wheezing noteddevereux612007scotlandprospective cohort2000 pregnant women, 1212 children5 ymaternal food-frequency questionnairehighest lowest maternal  intakes wheezingerkkola622009finlandprospective cohort1669 mother-child dyads5 ymaternal food-frequency questionnairehigher maternal  intake asthma allergic rhinitisgale632008ukprospective cohort466 mothers 178 children9 mo 9 ymaternal serum 25(oh)dmaternal  levels > 75 nmol/l atopic dermatitis asthmamiyake642010japanprospective cohort763 mother-child dyads16–24 momaternal food-frequency questionnairehigher maternal  intake decreased wheeze atopic dermatitismorales652012spainprospective cohort1724 children12 mo, 4–6 ymaternal plasma 25(oh)dincreased maternal 25(oh)d decreased  infections wheezing asthmarothers662011united statesprospective cohort219 childrenbirth 5 ycord blood 25(oh)dboth cord blood 25(oh)d aeroallergen sensitization allergic rhinitis asthma\nin birth 25(oh)d concentrations plasma whole blood pregnant women, median 25(oh)d concentrations ranged 20 29.5 ng/ml.60,63,65a 50% decrease maternal asthma 35 nmol/l increase 25(oh)d levels,  status asthma pregnancy.60however, maternal  intake, 25(oh)d concentrations  symptoms childhood observed.']
S32-PMC3427192	PMC3427192	4/2012	S32-PMC3427192	['HOWEVER, in THESE STUDIES, there were no associations between Cord-Blood 25(Oh)D concentrations and subsequent asthma at 5 y of age.59,66\ncollectively, these studies SUGGEST that the benefits of Vitamin D during early Life MAY BE LIMITED to its EFFECTS on Respiratory infections and Viral-induced wheezing and not asthma per se.17HOWEVER, ALTHOUGH Vitamin D MAY have IMPORTANT ROLES in Immune Regulation during early Life, excessive Vitamin D exposure MAY also be ASSOCIATED with adverse health outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 166), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 230), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 328), ('ANOMALY_CURIOUS_FINDING', 339), ('INCOMPLETE_EVIDENCE', 358), ('IMPORTANT_CONSIDERATION', 367), ('SUPERFICIAL_RELATIONSHIP', 377), ('INCOMPLETE_EVIDENCE', 452), ('SUPERFICIAL_RELATIONSHIP', 464)]	13	[('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('UBERON_0000104', 'life cycle', 218, 'life'), ('UBERON_0001004', 'respiratory system', 256, 'respiratory'), ('NCBITaxon_1', 'root', 283, 'viral'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('GO_0002521', 'leukocyte differentiation', 386, 'immune regulation'), ('UBERON_0002405', 'immune system', 386, 'immune'), ('UBERON_0000104', 'life cycle', 417, 'life'), ('CHEBI_27300', 'vitamin D', 433, 'vitamin D')]	0	['however, studies, cord-blood 25(oh)d concentrations asthma 5 age.59,66\ncollectively,  life  infections viral-induced wheezing asthma se.17however,  immune life, excessive  exposure outcomes.']
S47-PMC3427192	PMC3427192	4/2012	S47-PMC3427192	['given the LIMITATIONS ASSOCIATED with these epidemiologic studies, randomized controlled TRIALS of Vitamin D ARE NEEDED in children to BETTER UNDERSTAND the causal RELATIONSHIP between Vitamin D status and Respiratory outcomes such as asthma Control in this population.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 22), ('FUTURE_WORK', 89), ('FUTURE_WORK', 109), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 164)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 206, 'respiratory'), ('GO_0065007', 'biological regulation', 242, 'control')]	0	['given epidemiologic children causal  status  outcomes asthma population.']
S52-PMC3427192	PMC3427192	4/2012	S52-PMC3427192	['in these sub-analyses, Vitamin D3Supplementation was ASSOCIATED with a decreased risk of exacerbations compared with Placebo, with a relative risk of 0.17.75similarly, in a more RECENT randomized, double-blind 6-mo trial where 800 µg of inhaled Budesonide was administered daily to a small group of 48 children with asthma in the presence or absence of 500 iu/day of Vitamin D3, children receiving supplemental Vitamin D did not have a reduction in 25(Oh)D during the winter months and also had a reduced risk of asthma exacerbations triggered by acute Respiratory Viral infections.73these INITIAL FINDINGS SUGGEST that Vitamin D supplementation MAY have therapeutic benefit children with asthma, ALTHOUGH ADDITIONAL randomized, double-blind, placebo-controlled STUDIES ARE NEEDED.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 590), ('INCOMPLETE_EVIDENCE', 607), ('INCOMPLETE_EVIDENCE', 646), ('ANOMALY_CURIOUS_FINDING', 697), ('FUTURE_WORK', 706), ('FUTURE_WORK', 762)]	8	[('CHEBI_52915', 'phosphatediyl group', 23, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 23, 'vitamin D3supplementation'), ('CHEBI_26130', 'biological pigment', 117, 'placebo'), ('CHEBI_3219', 'bupropion', 245, 'budesonide'), ('CHEBI_33279', 'vitamin D5', 367, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 367, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 449, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 455, 'D'), ('UBERON_0001004', 'respiratory system', 553, 'respiratory'), ('NCBITaxon_1', 'root', 565, 'viral'), ('CHEBI_27300', 'vitamin D', 620, 'vitamin D')]	0	['sub-analyses, vitamin d3supplementation decreased exacerbations placebo, relative 0.17.75similarly, randomized, double-blind 6-mo 800 µg inhaled budesonide administered daily 48 children asthma presence absence 500 iu/day vitamin d3, children receiving supplemental  reduction 25(oh)d winter months asthma exacerbations triggered acute  viral infections.73these  supplementation children asthma, randomized, double-blind, placebo-controlled needed.']
S67-PMC3427192	PMC3427192	4/2012	S67-PMC3427192	['conclusion\nthere is a GROWING INTEREST in the ROLE of Vitamin D in asthma and Respiratory disorders across the Lifespan.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 78, 'respiratory'), ('UBERON_0000104', 'life cycle', 111, 'lifespan')]	0	['conclusion\nthere  asthma  disorders lifespan.']
S68-PMC3427192	PMC3427192	4/2012	S68-PMC3427192	['WHILE several observational STUDIES and a handful of SMALL clinical trials SUGGEST that Vitamin D MAY BE beneficial in asthma and wheezing disorders resulting from Respiratory Viral infections, findings are NOT CONSISTENT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 75), ('INCOMPLETE_EVIDENCE', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 207), ('INCOMPLETE_EVIDENCE', 211)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 164, 'respiratory'), ('NCBITaxon_1', 'root', 176, 'viral')]	0	[' asthma wheezing disorders resulting  viral infections, consistent.']
S69-PMC3427192	PMC3427192	4/2012	S69-PMC3427192	['these studies also DIFFER significantly in terms of the populations studied, the timing of the Vitamin D intake assessments and the 25(Oh)D sampling, the 25(Oh)D THRESHOLDS used for determining insufficiency, and the Respiratory outcomes of interest.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('PROBABLE_UNDERSTANDING', 162)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 154, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 154, '25'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 157, 'OH ... D'), ('UBERON_0001004', 'respiratory system', 217, 'respiratory')]	0	['terms populations studied, timing  intake 25(oh)d sampling, 25(oh)d insufficiency,  outcomes interest.']
S118-PMC3599191	PMC3599191	1/2013	S118-PMC3599191	['EVEN the lack of OTHER micro-Nutrients such as Selenium, Vitamins E, d and c, zinc and Folic Acid is RESPONSIBLE for the onset of disorders AFFECTING the Respiratory System in the offspring [46].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('CHEBI_33284', 'nutrient', 29, 'nutrients'), ('CHEBI_27568', 'selenium atom', 47, 'selenium'), ('CHEBI_27300', 'vitamin D', 57, 'vitamins E'), ('CHEBI_30751', 'formic acid', 87, 'folic acid'), ('UBERON_0001004', 'respiratory system', 154, 'respiratory system')]	0	['even micro-nutrients selenium, c, zinc folic acid onset disorders  offspring [46].']
S0-PMC3691177	PMC3691177	6/2013	S0-PMC3691177	['Prenatal Vitamin D supplementation and child Respiratory health: a randomised controlled trial\n\nabstract\n\nbackground\nOBSERVATIONAL studies SUGGEST high Prenatal Vitamin D intake MAY BE ASSOCIATED with reduced childhood wheezing.']	[('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 178), ('SUPERFICIAL_RELATIONSHIP', 185)]	4	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('UBERON_0001004', 'respiratory system', 45, 'Respiratory'), ('GO_0007565', 'female pregnancy', 152, 'prenatal'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]	0	['prenatal vitamin supplementation child  health: randomised trial\n\nabstract\n\nbackground\nobservational prenatal  intake childhood wheezing.']
S49-PMC3695234	PMC3695234	7/2013	S49-PMC3695234	['discussion\nACCORDING TO the results of the 2005-2006 national Health and nutrition examinations survey (nhanes), Vitamin D deficiency is ASSOCIATED with higher levels of Ige sensitization in children and adolescents.6to ASSESS the RELATIONSHIP between Vitamin D levels and Respiratory outcomes, other analyses were performed on the same survey data.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 137), ('QUESTION_ANSWERED_BY_THIS_WORK', 220), ('SUPERFICIAL_RELATIONSHIP', 231)]	4	[('UBERON_0000925', 'endoderm', 62, 'Health'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 170, 'IgE'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 273, 'respiratory')]	0	['discussion\naccording results 2005-2006 national nutrition examinations survey (nhanes),  higher levels ige sensitization children adolescents.6to  levels  outcomes, survey data.']
S50-PMC3695234	PMC3695234	7/2013	S50-PMC3695234	['a PROTECTIVE EFFECT for Vitamin D against wheezing and asthma was found to be strongest for non-atopic and older subjects, SUGGESTING that Vitamin D modifies the risk of allergic and Respiratory disease through multiple mechanisms.7\nalthough Vitamin D deficiency is DEFINED AS a Serum level <20 ng/ml of 25(Oh)d3, there is also an increasing CONCERN about Vitamin D INSUFFICIENCY, which is characterized by levels of 25(Oh)D3Between 20 and 29 ng/ml.8in THIS STUDY, we FOUND that most participants with ad COULD BE categorized as having Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 123), ('PROBABLE_UNDERSTANDING', 266), ('PROBABLE_UNDERSTANDING', 274), ('IMPORTANT_CONSIDERATION', 342), ('IMPORTANT_CONSIDERATION', 366), ('QUESTION_ANSWERED_BY_THIS_WORK', 453), ('INCOMPLETE_EVIDENCE', 468), ('INCOMPLETE_EVIDENCE', 505)]	10	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 183, 'respiratory'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('UBERON_0001977', 'blood serum', 279, 'serum'), ('CHEBI_30778', 'gallic acid', 304, '25(OH)'), ('CHEBI_27300', 'vitamin D', 356, 'vitamin D'), ('CHEBI_52744', 'fort orange 600', 417, '25(OH)D3between 20'), ('CHEBI_27300', 'vitamin D', 536, 'vitamin D')]	0	[' wheezing asthma non-atopic older subjects,  modifies allergic  disease mechanisms.7\nalthough  serum <20 ng/ml 25(oh)d3,  insufficiency, levels 25(oh)d3between 20 29 ng/ml.8in study, participants ad categorized  insufficiency.']
S54-PMC3702245	PMC3702245	6/2013	S54-PMC3702245	['Monocytes cultured in Vitamin D-deficient Plasma (Serum 25(Oh)D < 30 nmol/l) SHOWED significantly decreased Tolllike Receptor-mediated Expression of Cathelicidin (p < 0.05) compared with those conditioned in Vitamin D-sufficient Plasma (Serum 25(Oh)D > 75 nmol/l).93CONSISTENT with these in vitro FINDINGS, OBSERVATIONAL clinical DATA FOUND an ASSOCIATION between Vitamin D status in Cord Blood and the RISK of Lower Respiratory Tract infection in the first year of Life.94the risk of Respiratory syncytial Virus bronchiolitis in the first year of Life is increased by six-fold (ci 1.6–24.9) in infants with Cord Blood 25(Oh)D < 50 nmol/l compared with infants with 25(Oh)D > 75 nmol/l.']	[('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('INCOMPLETE_EVIDENCE', 297), ('INCOMPLETE_EVIDENCE', 307), ('FUTURE_WORK', 330), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 344), ('IMPORTANT_CONSIDERATION', 403)]	9	[('CL_0000576', 'monocyte', 0, 'Monocytes'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 42, 'plasma'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('PR_000001660', 'prostaglandin F2-alpha receptor', 108, 'tolllike receptor'), ('GO_0010467', 'gene expression', 135, 'expression'), ('PR_000006009', 'alpha-catulin', 149, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 229, 'plasma'), ('UBERON_0001977', 'blood serum', 237, 'serum'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 243, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 384, 'cord'), ('UBERON_0000178', 'blood', 389, 'blood'), ('UBERON_0004905', 'articulation', 411, 'lower respiratory tract'), ('UBERON_0000104', 'life cycle', 466, 'life'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory'), ('NCBITaxon_1', 'root', 507, 'virus'), ('UBERON_0000104', 'life cycle', 548, 'life'), ('UBERON_0002240', 'spinal cord', 608, 'cord'), ('UBERON_0000178', 'blood', 613, 'blood'), ('CHEBI_71657', 'versiconol acetate', 619, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 619, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 666, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 666, '25(OH)D')]	0	['monocytes cultured -deficient plasma (serum 25(oh)d 30 nmol/l) decreased tolllike receptor-mediated expression cathelicidin (p 0.05) -sufficient plasma (serum 25(oh)d > 75 nmol/l).93consistent findings,  status cord blood respiratory tract infection year life.94the  syncytial virus bronchiolitis year life six-fold (ci 1.6–24.9) infants cord blood 25(oh)d 50 nmol/l infants 25(oh)d > 75 nmol/l.']
S56-PMC3702245	PMC3702245	6/2013	S56-PMC3702245	['IN CONTRAST, an OBSERVATIONAL study REPORTED an increased RISK of infantile eczema and pneumonia in ASSOCIATION with maternal Serum 25(Oh)D > 75 nmol/l in the last trimester.76HOWEVER, another RECENT STUDY with a larger sample size from the same institution DID NOT FIND an ASSOCIATION between maternal 25(Oh)d > 75 nmol/l in late Pregnancy and eczema or asthma at 12 months and three and six years of age.97there was no report on the ASSOCIATION between maternal Vitamin D status and Respiratory infections in the latter study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 435)]	10	[('UBERON_0001977', 'blood serum', 126, 'serum'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 303, '25(OH)'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 303, '25(OH'), ('GO_0007565', 'female pregnancy', 331, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory')]	0	['contrast, infantile eczema pneumonia maternal serum 25(oh)d > 75 nmol/l last trimester.76however, sample institution maternal 25(oh)d > 75 nmol/l late pregnancy eczema asthma 12 months three six age.97there maternal  status  infections latter study.']
S24-PMC3704911	PMC3704911	7/2013	S24-PMC3704911	['additionally, Prenatal DEFICIENCIES in Vitamins D and E HAVE BEEN ASSOCIATED with increased incidences of Respiratory difficulties, including wheezing and asthma, in the offspring [7], and maternal Vitamin D deficiencies HAVE BEEN RELATED to observed hyper-Locomotion in the Adult Rat [8].']	[('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 221), ('SUPERFICIAL_RELATIONSHIP', 231)]	5	[('GO_0007565', 'female pregnancy', 14, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamins D'), ('PR_000006444', 'diacylglycerol kinase delta', 48, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 54, 'E'), ('UBERON_0001004', 'respiratory system', 106, 'respiratory'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0040011', 'locomotion', 257, 'locomotion'), ('UBERON_0007023', 'adult organism', 275, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 281, 'rat')]	0	['additionally, prenatal  e incidences  difficulties, wheezing asthma, offspring [7], maternal  hyper-locomotion adult rat [8].']
S3-PMC3717170	PMC3717170	5/2013	S3-PMC3717170	['THIS REPORT summarizes RECENT RESEARCH on the ROLES for Vitamin D in cancer, Immunity and Autoimmune diseases, Cardiovascular and Respiratory health, Pregnancy, obesity, Erythropoiesis, diabetes, muscle function, and Aging.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007566', 'embryo implantation', 77, 'immunity'), ('UBERON_0001442', 'skeleton of manus', 90, 'autoimmune'), ('UBERON_0004535', 'cardiovascular system', 111, 'cardiovascular'), ('UBERON_0001004', 'respiratory system', 130, 'respiratory'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0030218', 'erythrocyte differentiation', 170, 'erythropoiesis'), ('GO_0007568', 'aging', 217, 'aging')]	0	['summarizes  cancer, immunity autoimmune diseases, cardiovascular  health, pregnancy, obesity, erythropoiesis, diabetes, muscle function, aging.']
S340-PMC3728489	PMC3728489	7/2013	S340-PMC3728489	['they also HAVE BEEN ASSOCIATED with increased offspring risk for Respiratory infections (Vitamin D), Intestinal inflammation and diarrhea (Folate and Vitamin A), allergy and asthma (Vitamin E and Folate) and Neurodevelopmental disorders (Folate).']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('UBERON_0001004', 'respiratory system', 65, 'respiratory'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0000160', 'intestine', 101, 'intestinal'), ('CHEBI_30863', '5-azaorotic acid', 139, 'folate'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin E'), ('CHEBI_30863', '5-azaorotic acid', 196, 'folate'), ('GO_0007399', 'nervous system development', 208, 'neurodevelopmental'), ('CHEBI_30863', '5-azaorotic acid', 238, 'folate')]	0	['offspring  infections (), intestinal inflammation diarrhea (folate ), allergy asthma folate) neurodevelopmental disorders (folate).']
S7-PMC3798907	PMC3798907	8/2013	S7-PMC3798907	['the OBSERVED ASSOCIATIONS between Vitamin E and childhood Respiratory disease are COMPLEX, and the nature and form of nutritional intervention NEED TO BE carefully CONSIDERED before inclusion in trials.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('DIFFICULT_TASK', 82), ('FUTURE_WORK', 143), ('FUTURE_WORK', 164)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin E'), ('UBERON_0001004', 'respiratory system', 58, 'respiratory')]	0	[' childhood  disease complex, nature form nutritional inclusion trials.']
S119-PMC3814422	PMC3814422	10/2013	S119-PMC3814422	['furthermore, from a PUBLIC HEALTH perspective Maternal Pregnancy Vitamin D as a risk FACTOR for future offspring atopy or Respiratory health would only be of MAJOR IMPORTANCE IF it was relevant to most of the population and not ONLY those members at the extremes.']	[('IMPORTANT_CONSIDERATION', 20), ('SUPERFICIAL_RELATIONSHIP', 85), ('IMPORTANT_CONSIDERATION', 158), ('IMPORTANT_CONSIDERATION', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ANOMALY_CURIOUS_FINDING', 228)]	6	[('GO_0007618', 'mating', 46, 'maternal'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 122, 'respiratory')]	0	['furthermore, maternal pregnancy  offspring atopy  population members extremes.']
S130-PMC3814422	PMC3814422	10/2013	S130-PMC3814422	['ALTHOUGH we COULD NOT directly investigate the ASSOCIATION of maternal 25(Oh)D with Early Life Respiratory infections, the LACK OF ASSOCIATION with transient early wheezing phenotype ARGUES AGAINST a PROTECTIVE EFFECT of Prenatal Vitamin D on Respiratory Viral infections in early childhood.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 12), ('ANOMALY_CURIOUS_FINDING', 18), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 131), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 200), ('SUPERFICIAL_RELATIONSHIP', 211)]	9	[('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 71, '25(OH ... D'), ('UBERON_0001847', 'lobule of pinna', 84, 'early life'), ('UBERON_0001004', 'respiratory system', 95, 'respiratory'), ('GO_0007565', 'female pregnancy', 221, 'prenatal'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 243, 'respiratory'), ('NCBITaxon_1', 'root', 255, 'viral')]	0	['although maternal 25(oh)d life  infections, transient wheezing phenotype prenatal   viral infections childhood.']
S63-PMC3827489	PMC3827489	10/2013	S63-PMC3827489	['Vitamin D insufficiency/deficiency and Respiratory diseases\nemerging EVIDENCE SUGGESTS that Vitamin D plays an ESSENTIAL ROLE in the Modulation Of the Immune Responses.']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 111), ('SUPERFICIAL_RELATIONSHIP', 121)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001004', 'respiratory system', 39, 'respiratory'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0006880', 'intracellular sequestering of iron ion', 133, 'modulation of ... immune responses'), ('UBERON_0002405', 'immune system', 151, 'immune')]	0	['vitamin insufficiency/deficiency  diseases\nemerging  plays immune responses.']
S75-PMC3827489	PMC3827489	10/2013	S75-PMC3827489	['these observational and clinical studies INDICATE a beneficial EFFECT of Vitamin D supplementation in Vitamin D deficient children with asthma or acute or chronic Respiratory infections.']	[('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 163, 'respiratory')]	0	[' supplementation  children asthma acute chronic  infections.']
S172-PMC3829803	PMC3829803	11/2013	S172-PMC3829803	['both Vitamin A supplementation and treatment have either no or negative EFFECTS on Respiratory Tract infections including the Common paramyxovirus, Respiratory syncytial virus (Rsv) [72]–[74].']	[('SUPERFICIAL_RELATIONSHIP', 72)]	1	[('CHEBI_27300', 'vitamin D', 5, 'vitamin A'), ('UBERON_0000065', 'respiratory tract', 83, 'respiratory tract'), ('NCBITaxon_33208', 'Metazoa', 126, 'common'), ('UBERON_0001004', 'respiratory system', 148, 'respiratory'), ('NCBITaxon_10088', 'Mus <genus>', 177, 'RSV')]	0	[' supplementation treatment respiratory tract infections paramyxovirus,  syncytial virus (rsv) [72]–[74].']
S12-PMC3933171	PMC3933171	3/2014	S12-PMC3933171	['introduction\nlow Vitamin D (vitd) status is a risk FACTOR for rickets and HAS BEEN ASSOCIATED with INCREASED prevalence of Respiratory infections and other adverse health outcomes in infants and children.12in response to the CONCERN about widespread childhood vitd deficiency, professional bodies have RECOMMENDED vitd intake of 400\u2005iu/ day for all infants.13the european society for paediatrics gastroenterology, hepatology and nutrition RECOMMENDS 800–1000\u2005iu/day for preterm infants.4based on BIOMARKERS of vitd status MOSTLY in adults, Serum 25-Hydroxyvitamin-D [25(Oh)D] concentration ≥50\u2005nmol/l was also RECOMMENDED.13HOWEVER, the functional benefit of this level is CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 225), ('FUTURE_WORK', 302), ('FUTURE_WORK', 439), ('SUPERFICIAL_RELATIONSHIP', 496), ('PROBABLE_UNDERSTANDING', 522), ('FUTURE_WORK', 610), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 622), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 673)]	12	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 123, 'respiratory'), ('UBERON_0001977', 'blood serum', 540, 'serum'), ('CHEBI_67320', 'majusculamide A', 546, '25-hydroxyvitamin-D'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D')]	0	['introduction\nlow  (vitd) status rickets  infections outcomes infants children.12in response childhood vitd deficiency, professional bodies vitd intake 400\u2005iu/ day infants.13the european society paediatrics gastroenterology, hepatology nutrition 800–1000\u2005iu/day preterm infants.4based vitd status adults, serum 25-hydroxyvitamin-d [25(oh)d] concentration ≥50\u2005nmol/l recommended.13however, functional controversial.']
S485-PMC4113768	PMC4113768	7/2014	S485-PMC4113768	['in addition, an ASSOCIATION between INADEQUATE Vitamin D levels and impaired Lung function COULD BE EXPLAINED by an INCREASED RISK of Respiratory infections or a negative INFLUENCE on muscle function.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 36), ('INCOMPLETE_EVIDENCE', 91), ('PROBABLE_UNDERSTANDING', 100), ('IMPORTANT_CONSIDERATION', 116), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002048', 'lung', 77, 'lung'), ('UBERON_0001004', 'respiratory system', 134, 'respiratory')]	0	['addition,  levels lung  infections muscle function.']
S690-PMC4113768	PMC4113768	7/2014	S690-PMC4113768	['methods: as part of a study examining the IMPACT of the introduction of the london low emission zone on children’s Respiratory health, we ASSESSED the feasibility and acceptability of a Finger prick dried Blood spot method for assessing Vitamin D status (pro-diagnostics, london, uk).']	[('SUPERFICIAL_RELATIONSHIP', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 138)]	2	[('UBERON_0001004', 'respiratory system', 115, 'respiratory'), ('UBERON_0002389', 'manual digit', 186, 'finger'), ('UBERON_0000178', 'blood', 205, 'blood'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]	0	['methods: introduction london emission zone children’s  health, acceptability finger prick dried blood spot  status (pro-diagnostics, london, uk).']
S1641-PMC4113768	PMC4113768	7/2014	S1641-PMC4113768	['background: meta-analysis of clinical trials of Vitamin D supplementation for the PREVENTION of acute Respiratory infection (ari) SHOWS a PROTECTIVE EFFECT in the general population, BUT there is CONTROVERSY regarding the OPTIMAL dosing regimen.']	[('SUPERFICIAL_RELATIONSHIP', 82), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 138), ('SUPERFICIAL_RELATIONSHIP', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('IMPORTANT_CONSIDERATION', 222)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 102, 'respiratory')]	0	['background: meta-analysis  supplementation acute  infection (ari) population, regarding dosing regimen.']
S1691-PMC4113768	PMC4113768	7/2014	S1691-PMC4113768	['background: MANY epidemiological STUDIES in RECENT years SUGGEST that Vitamin D is ASSOCIATED with a high RISK of osteoporotic fractures, malignancy of Breast, Colon, Prostate and many Respiratory diseases.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0000310', 'breast', 152, 'breast'), ('UBERON_0001155', 'colon', 160, 'colon'), ('UBERON_0002367', 'prostate gland', 167, 'prostate'), ('GO_0045333', 'cellular respiration', 185, 'respiratory'), ('UBERON_0001004', 'respiratory system', 185, 'respiratory')]	0	['background: epidemiological  osteoporotic fractures, malignancy breast, colon, prostate  diseases.']
S2052-PMC4113768	PMC4113768	7/2014	S2052-PMC4113768	['ONLY a LIMITED NUMBER OF studies EXAMINED the RELATIONSHIP between Vitamin D status and the prevalence and severity of Respiratory infections in children.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 46)]	4	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 119, 'respiratory')]	0	[' status  infections children.']
S3209-PMC4113768	PMC4113768	7/2014	S3209-PMC4113768	['25-Hydroxy Vitamin D3(25(Oh)D3) Modulates Innate Immunity and RECENT EVIDENCE HIGHLIGHTS ASSOCIATIONS between Vitamin D deficiency and several Respiratory illnesses.']	[('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 89)]	3	[('CHEBI_43141', '3-hydroxypropoxy group', 0, '25-hydroxy'), ('CHEBI_33279', 'vitamin D5', 11, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 11, 'vitamin D3'), ('CHEBI_62946', 'ammonium sulfate', 22, '25(OH)D3'), ('GO_0065007', 'biological regulation', 32, 'modulates'), ('GO_0045087', 'innate immune response', 42, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 143, 'respiratory')]	0	['25-hydroxy vitamin d3(25(oh)d3) innate immunity   illnesses.']
S3300-PMC4113768	PMC4113768	7/2014	S3300-PMC4113768	['there are many mechanisms whereby Vitamin D CAN reduce the RISK of cvd including reduced risk of diabetes mellitus and Metabolic syndrome, EFFECTS on Blood pressure, Cholesterol, cytokines, Endothelial disruption, Glucose Regulation, Insulin resistance, muscle strength, Respiratory infections, and vascular calcification.']	[('INCOMPLETE_EVIDENCE', 44), ('IMPORTANT_CONSIDERATION', 59), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0008152', 'metabolic process', 119, 'metabolic'), ('UBERON_0000178', 'blood', 150, 'blood'), ('CHEBI_16113', 'cholesterol', 166, 'cholesterol'), ('UBERON_0001986', 'endothelium', 190, 'endothelial'), ('CHEBI_17234', 'glucose', 214, 'glucose'), ('GO_0006094', 'gluconeogenesis', 214, 'glucose regulation'), ('PR_000045358', 'insulin family protein', 234, 'insulin'), ('UBERON_0001004', 'respiratory system', 271, 'respiratory')]	0	['mechanisms whereby  cvd diabetes mellitus metabolic syndrome, blood pressure, cholesterol, cytokines, endothelial disruption, glucose regulation, insulin resistance, muscle strength,  infections, vascular calcification.']
S76-PMC4377870	PMC4377870	3/2015	S76-PMC4377870	['antioxidants including Lycopene APPEAR to have positive INFLUENCES in Respiratory conditions, further detail is provided below on EVIDENCE for Vitamin C, Vitamin E and Flavonoids and their ROLE in the maternal diet, diets of children and Adults with asthma and Adults with copd.']	[('ANOMALY_CURIOUS_FINDING', 32), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 189)]	4	[('CHEBI_15948', 'lycopene', 23, 'lycopene'), ('UBERON_0001004', 'respiratory system', 70, 'respiratory'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin E'), ('CHEBI_72544', 'flavonoids', 168, 'flavonoids'), ('UBERON_0007023', 'adult organism', 238, 'adults'), ('UBERON_0007023', 'adult organism', 261, 'adults')]	0	['antioxidants lycopene positive  conditions, detail  flavonoids maternal diet, diets children adults asthma adults copd.']
S140-PMC4377870	PMC4377870	3/2015	S140-PMC4377870	['the review by foong and zosky [111] presents the CURRENT EVIDENCE for the ROLE of Vitamin D deficiency in disease onset, progression and exacerbation in Respiratory infections, asthma and copd.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 153, 'respiratory')]	0	['foong zosky [111] presents  disease onset, progression exacerbation  infections, asthma copd.']
S146-PMC4377870	PMC4377870	3/2015	S146-PMC4377870	['epidemiological EVIDENCE LINKS low levels of Vitamin D with wheeze and Respiratory infections, THOUGH EVIDENCE for the LINK with asthma onset is weak and INCONSISTENT [111].']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ANOMALY_CURIOUS_FINDING', 95), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 154)]	7	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 71, 'respiratory')]	0	['epidemiological levels  wheeze  infections, asthma onset [111].']
S150-PMC4377870	PMC4377870	3/2015	S150-PMC4377870	['several OBSERVATIONAL STUDIES SUPPORT the ROLE of Vitamin D for protection against Respiratory conditions in children.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 83, 'respiratory')]	0	['several   conditions children.']
S164-PMC4377870	PMC4377870	3/2015	S164-PMC4377870	['the extra-Skeletal EFFECTS of Vitamin D are WELL DOCUMENTED in both asthma and copd, and deficiency is ASSOCIATED with negative Respiratory and Immune outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('UBERON_0004288', 'skeleton', 10, 'skeletal'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 128, 'respiratory'), ('UBERON_0002405', 'immune system', 144, 'immune')]	0	['extra-skeletal  asthma copd,  immune outcomes.']
S249-PMC4377870	PMC4377870	3/2015	S249-PMC4377870	['a whole Foods approach to Nutrient supplementation—for example, increasing intake of fruit and vegetables, has the benefit of increasing intake of multiple Nutrients, including vitamin C, Vitamin E, Carotenoids and Flavonoids and SHOWS more promise in Respiratory diseases in terms of reducing risk of copd [3] and incidence of asthma exacerbations [25].']	[('INCOMPLETE_EVIDENCE', 230)]	1	[('CHEBI_33290', 'food', 8, 'foods'), ('CHEBI_33284', 'nutrient', 26, 'nutrient'), ('CHEBI_33284', 'nutrient', 156, 'nutrients'), ('CHEBI_18245', 'carboxylato group', 185, 'C'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin E'), ('CHEBI_50815', 'norgestimate', 199, 'carotenoids'), ('CHEBI_72544', 'flavonoids', 215, 'flavonoids'), ('UBERON_0001004', 'respiratory system', 252, 'respiratory')]	0	['whole foods nutrient supplementation—for example, intake fruit vegetables, intake nutrients, vitamin c, carotenoids flavonoids  diseases terms reducing copd [3] asthma exacerbations [25].']
S251-PMC4377870	PMC4377870	3/2015	S251-PMC4377870	['it APPEARS that Vitamin D is IMPORTANT in Respiratory diseases and infections, HOWEVER the temporal ROLE of Vitamin D deficiency in disease onset, pathogenesis and exacerbations and WHETHER supplementation is indicated is yet to be clarified.']	[('ANOMALY_CURIOUS_FINDING', 3), ('IMPORTANT_CONSIDERATION', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('ANOMALY_CURIOUS_FINDING', 79), ('SUPERFICIAL_RELATIONSHIP', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 42, 'respiratory'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]	0	['  diseases infections, temporal  disease onset, pathogenesis exacerbations supplementation clarified.']
S192-PMC4448820	PMC4448820	5/2015	S192-PMC4448820	['INITIALLY, THESE OBSERVATIONS were RESTRICTED to Monocytes and Macrophages; HOWEVER, RECENT STUDIES SHOWED that cathelicidin Antimicrobial peptide (camp) is induced by Vitamin D in Keratinocytes and Respiratory and Bladder Epithelial Cells (113).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 100)]	7	[('CL_0000576', 'monocyte', 49, 'monocytes'), ('CL_0000235', 'macrophage', 63, 'macrophages'), ('CHEBI_65381', 'albizoside C', 125, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CL_0000312', 'keratinocyte', 181, 'keratinocytes'), ('CL_0000006', 'neuronal receptor cell', 199, 'respiratory ...'), ('GO_0045333', 'cellular respiration', 199, 'respiratory'), ('UBERON_0001004', 'respiratory system', 199, 'respiratory'), ('CL_1001428', 'bladder urothelial cell', 215, 'bladder epithelial cells'), ('UBERON_0001915', 'endothelium of capillary', 215, 'bladder epithelial')]	0	['initially, monocytes macrophages; however, cathelicidin antimicrobial peptide (camp) induced  keratinocytes  bladder epithelial cells (113).']
S581-PMC4448820	PMC4448820	5/2015	S581-PMC4448820	['ALTHOUGH Vitamin A MAY have a preventive EFFECT on the incidence or severity of diarrhea and measles in community trials, it has had LITTLE or the OPPOSITE EFFECT on Respiratory infections (105).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('SUPERFICIAL_RELATIONSHIP', 156)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 166, 'respiratory')]	0	['although  diarrhea measles community trials,  infections (105).']
S48-PMC4499946	PMC4499946	7/2015	S48-PMC4499946	['clinical, biochemical, and microbiological Surveillance of enrolled mother-infant pairs will enable a range of secondary objectives to be addressed, including (1) estimation of the EFFECT of maternal Vitamin D supplementation on the incidence of acute Respiratory infections (aris) during early infancy; (2) exploration of the ROLES of specific hormones, Nutrients, environmental Contaminants, and inflammatory markers in the mediation or modification of the EFFECT of Vitamin D on fetal and infant growth, with particular emphasis on the ROLE of the Parathyroid hormone (pth) system; and (3) investigation of the ROLE of epigenetic modification of Genes involved in Perinatal Vitamin D Metabolism in infant stunting.']	[('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 327), ('SUPERFICIAL_RELATIONSHIP', 459), ('SUPERFICIAL_RELATIONSHIP', 539), ('SUPERFICIAL_RELATIONSHIP', 614)]	5	[('GO_0065007', 'biological regulation', 43, 'surveillance'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 252, 'respiratory'), ('CHEBI_33284', 'nutrient', 355, 'nutrients'), ('CHEBI_60688', 'EC 4.2.1.20 (tryptophan synthase) inhibitor', 380, 'contaminants'), ('CHEBI_27300', 'vitamin D', 469, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 551, 'parathyroid'), ('SO_0000704', 'gene', 649, 'genes'), ('GO_0036268', 'swimming', 667, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 667, 'perinatal'), ('CHEBI_27300', 'vitamin D', 677, 'vitamin D'), ('GO_0008152', 'metabolic process', 687, 'metabolism')]	0	['clinical, biochemical, microbiological enrolled mother-infant pairs secondary addressed, (1) maternal  supplementation acute  infections (aris) infancy; (2) hormones, nutrients, environmental contaminants, inflammatory  fetal infant growth, parathyroid hormone (pth) system; (3) epigenetic genes perinatal  metabolism infant stunting.']
S87-PMC4514967	PMC4514967	12/2014	S87-PMC4514967	['low Cord Blood Vitamin D levels are a PREDICTOR of subsequent infant Respiratory infections.70,71HOWEVER, data from clinical trials are too LIMITED to draw conclusions about the efficacy and SAFETY of Vitamin D supplementation in Pregnancy.72meta-analyses have HIGHLIGHTED THE NEED to extend endpoints in intervention trials of multiple Micronutrients in Pregnancy.30the timing of Nutrient interventions during Pregnancy or before Conception is an IMPORTANT clinical study parameter to CONSIDER in any meta-analysis designed to evaluate the EFFECTS of an intervention or interventions and the OBSERVED effect size.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 273), ('FUTURE_WORK', 277), ('IMPORTANT_CONSIDERATION', 448), ('FUTURE_WORK', 486), ('SUPERFICIAL_RELATIONSHIP', 541), ('INCOMPLETE_EVIDENCE', 593)]	11	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 69, 'respiratory'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0007565', 'female pregnancy', 230, 'pregnancy'), ('CHEBI_33839', 'macromolecule', 337, 'micronutrients'), ('GO_0007565', 'female pregnancy', 355, 'pregnancy'), ('CHEBI_33284', 'nutrient', 381, 'nutrient'), ('GO_0007565', 'female pregnancy', 411, 'pregnancy'), ('GO_0007620', 'copulation', 431, 'conception')]	0	['low cord blood  levels infant  infections.70,71however, draw  supplementation pregnancy.72meta-analyses endpoints micronutrients pregnancy.30the timing nutrient pregnancy parameter meta-analysis size.']
S108-PMC4684854	PMC4684854	12/2015	S108-PMC4684854	['for example, PRELIMINARY EVIDENCE SUGGESTS that insufficient levels of Prenatal Vitamin D MAY BE a factor in the development of autism [74] and lower Respiratory infections [75].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 90)]	3	[('GO_0007565', 'female pregnancy', 71, 'prenatal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 150, 'respiratory')]	0	['example, levels prenatal  autism [74]  infections [75].']
S167-PMC4689556	PMC4689556	12/2015	S167-PMC4689556	['given that SOME observational studies SUGGEST adverse child Respiratory health outcomes are ASSOCIATED with very high maternal Vitamin D level during Pregnancy, empiric data ARE NEEDED before high dose Prenatal Vitamin D supplementation CAN be routinely RECOMMENDED [44].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 92), ('FUTURE_WORK', 174), ('INCOMPLETE_EVIDENCE', 237), ('FUTURE_WORK', 254)]	6	[('UBERON_0001004', 'respiratory system', 60, 'respiratory'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0007565', 'female pregnancy', 202, 'prenatal'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]	0	['given child  outcomes maternal  pregnancy, empiric dose prenatal  supplementation routinely [44].']
S15-PMC4691762	PMC4691762	12/2015	S15-PMC4691762	['introduction\nVitamin D is LIKELY to play a ROLE in early infant Immune health, with EMERGING EVIDENCE that early Life Vitamin D deficiency increases the risk of developing childhood diseases such as Food allergy1lower Respiratory infections (lris)2and eczema.3a marked shift to Vitamin D deficiency in early Life in modern populations MAY BE an underlying driver of the REPORTED rise in allergic diseases including Food allergy and eczema.']	[('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 370)]	5	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0002405', 'immune system', 64, 'immune'), ('UBERON_0000104', 'life cycle', 113, 'life'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_33290', 'food', 199, 'food'), ('UBERON_0001004', 'respiratory system', 218, 'respiratory'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D'), ('UBERON_0000104', 'life cycle', 308, 'life'), ('CHEBI_33290', 'food', 415, 'food')]	0	['introduction\nvitamin play infant immune health, life  childhood diseases food allergy1lower  infections (lris)2and eczema.3a marked  life modern populations rise allergic diseases food allergy eczema.']
S17-PMC4691762	PMC4691762	12/2015	S17-PMC4691762	['RECENT EVIDENCE SUGGESTS that low Vitamin D at Birth or during Infancy is ASSOCIATED with an increased RISK of Food allergy6and eczema.7in addition Food allergy and eczema prevalence is higher the further from the equator a Person resides, LENDING SUPPORT to the HYPOTHESES that low Vitamin D (through low ultraviolet (uv) exposure) MAY play a ROLE in aberrant Immune Development in early Life and increase the risk of developing Food allergy and eczema.3food allergy is one of the earliest manifestations of the Immune deviation,8but also STRONGLY COASSOCIATES with eczema in infancy and asthma later in Life.9\nVitamin D supplementation in the first year of Life has also BEEN ASSOCIATED with a reduced risk of lris10and reduced recovery time in infants with acute bronchiolitis.11since early Life wheezy lris are also strongly ASSOCIATED with longer term respiratory outcomes including asthma12understanding the ROLE of Vitamin D in the RISK of early Life Respiratory diseases is also IMPORTANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 263), ('INCOMPLETE_EVIDENCE', 263), ('INCOMPLETE_EVIDENCE', 333), ('SUPERFICIAL_RELATIONSHIP', 344), ('PROBABLE_UNDERSTANDING', 540), ('SUPERFICIAL_RELATIONSHIP', 549), ('ANOMALY_CURIOUS_FINDING', 673), ('SUPERFICIAL_RELATIONSHIP', 678), ('SUPERFICIAL_RELATIONSHIP', 829), ('SUPERFICIAL_RELATIONSHIP', 914), ('IMPORTANT_CONSIDERATION', 939), ('IMPORTANT_CONSIDERATION', 987)]	18	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007567', 'parturition', 47, 'birth'), ('GO_0007631', 'feeding behavior', 63, 'infancy'), ('CHEBI_33290', 'food', 111, 'food'), ('CHEBI_33290', 'food', 148, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 224, 'person'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0001822', 'kidney development', 361, 'immune development'), ('UBERON_0002405', 'immune system', 361, 'immune'), ('UBERON_0000104', 'life cycle', 389, 'life'), ('CHEBI_33290', 'food', 430, 'food'), ('UBERON_0002405', 'immune system', 513, 'immune'), ('UBERON_0000104', 'life cycle', 605, 'life'), ('CHEBI_28384', 'vitamin K', 612, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 659, 'life'), ('UBERON_0000104', 'life cycle', 794, 'life'), ('CHEBI_27300', 'vitamin D', 922, 'vitamin D'), ('UBERON_0000104', 'life cycle', 953, 'life'), ('UBERON_0001004', 'respiratory system', 958, 'respiratory')]	0	['recent  birth infancy food allergy6and eczema.7in addition food allergy eczema higher equator person resides,  (through ultraviolet (uv) exposure) play aberrant immune life increase food allergy eczema.3food allergy manifestations immune deviation,8but eczema infancy asthma life.9\nvitamin supplementation year life lris10and recovery infants acute bronchiolitis.11since life wheezy lris longer term respiratory outcomes asthma12understanding  life  diseases important.']
S20-PMC4691762	PMC4691762	12/2015	S20-PMC4691762	['objectives\nwith the ultimate GOAL of developing improved PUBLIC HEALTH GUIDELINES for Vitamin D supplementation of infants, we AIM TO DETERMINE IF Vitamin D supplementation in infants from 6 to 8\u2005weeks of age LEADS to a reduction in the following during the first year of Life:\nchallenge-proven Food allergy\nlower Respiratory infections\nFood sensitisation\ndoctor diagnosed eczema\nvitamin D deficiency\n\nmethods and analysis\n\ndesign\nvitality is a double-blind, randomised, placebo-controlled trial of Vitamin D supplementation during the first year of Life.']	[('IMPORTANT_CONSIDERATION', 29), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 71), ('FUTURE_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144), ('SUPERFICIAL_RELATIONSHIP', 209)]	8	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0000104', 'life cycle', 272, 'life'), ('CHEBI_33290', 'food', 295, 'food'), ('UBERON_0001004', 'respiratory system', 314, 'respiratory'), ('CHEBI_33290', 'food', 337, 'Food'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 388, 'D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('UBERON_0000104', 'life cycle', 550, 'life')]	0	['objectives\nwith ultimate  supplementation infants,  supplementation infants 6 8\u2005weeks age reduction following year life:\nchallenge-proven food allergy\nlower  infections\nfood sensitisation\ndoctor diagnosed eczema\nvitamin deficiency\n\nmethods analysis\n\ndesign\nvitality double-blind, randomised, placebo-controlled  supplementation year life.']
S106-PMC4691762	PMC4691762	12/2015	S106-PMC4691762	['we will not be monitoring Serum 25(Oh)D for safety reasons nor considering the association between 25(Oh)D and outcome frequency given that 400\u2005Iu HAS BEEN SHOWN to be SAFE in term babies,1926preterm infants27and is the current RECOMMENDED dose in the usa, canada, the uk and europe.18\n\ndiscussion\nthe results of the vitality trial will determine WHETHER Vitamin D supplementation has a ROLE in optimising infant Immune health in the first year of Life, reducing the risk of allergic disease and Respiratory diseases.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 168), ('FUTURE_WORK', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('SUPERFICIAL_RELATIONSHIP', 387)]	5	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 32, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 99, '25(OH)D'), ('CHEBI_17883', 'hydrogen chloride', 144, 'IU'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin D'), ('UBERON_0002405', 'immune system', 413, 'immune'), ('UBERON_0000104', 'life cycle', 448, 'life'), ('UBERON_0001004', 'respiratory system', 496, 'respiratory')]	0	['serum 25(oh)d 25(oh)d outcome frequency 400\u2005iu term babies,1926preterm infants27and dose usa, canada, uk europe.18\n\ndiscussion\nthe results  supplementation optimising infant immune year life, reducing allergic disease  diseases.']
S118-PMC4691762	PMC4691762	12/2015	S118-PMC4691762	['it acts by inducing Antimicrobial peptides in Epithelial Cells, Neutrophils and Macrophages28And increases transcription of the innate Immune protein (hcap-18) which is capable of killing a wide variety of Viral and bacterial pathogens.29THESE FINDINGS are SUPPORTED by the observation that Vitamin D receptor polymorphisms (which decrease the bioavailability of Vitamin D to the cell) are ASSOCIATED with more SEVERE bronchiolitis30and that defective Control Of Vitamin D receptor-Mediated Cell Signalling PREDISPOSES to SEVERE Respiratory syncytial Virus bronchiolitis.31\n\nconclusions\ninternational enthusiasm for supplemental Vitamin D has OUTPACED AVAILABLE EVIDENCE on its EFFECTIVENESS32AND in fact ARGUMENT for routine supplementation is in equipoise.']	[('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 411), ('SUPERFICIAL_RELATIONSHIP', 507), ('IMPORTANT_CONSIDERATION', 522), ('ANOMALY_CURIOUS_FINDING', 643), ('ANOMALY_CURIOUS_FINDING', 643), ('INCOMPLETE_EVIDENCE', 652), ('SUPERFICIAL_RELATIONSHIP', 678), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 705)]	11	[('CHEBI_65381', 'albizoside C', 20, 'antimicrobial'), ('CL_0000066', 'epithelial cell', 46, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 46, 'epithelial'), ('CL_0000775', 'neutrophil', 64, 'neutrophils'), ('CL_0000091', 'Kupffer cell', 80, 'macrophages28and'), ('UBERON_0002405', 'immune system', 135, 'immune'), ('NCBITaxon_1', 'root', 206, 'viral'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('GO_0060070', 'canonical Wnt signaling pathway', 452, 'control of ... -mediated cell signalling'), ('CHEBI_27300', 'vitamin D', 463, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 529, 'respiratory'), ('NCBITaxon_1', 'root', 551, 'virus'), ('CHEBI_27300', 'vitamin D', 629, 'vitamin D')]	0	['inducing antimicrobial peptides epithelial cells, neutrophils macrophages28and transcription innate immune protein (hcap-18) capable killing viral bacterial pathogens.29these  receptor polymorphisms (which decrease bioavailability  cell) bronchiolitis30and defective  receptor-mediated cell signalling  syncytial virus bronchiolitis.31\n\nconclusions\ninternational supplemental  routine supplementation equipoise.']
S113-PMC4889866	PMC4889866	5/2016	S113-PMC4889866	['HOWEVER, most studies that SHOWED PROTECTIVE EFFECT of Vitamin D against Respiratory diseases were of interventional studies that used supplementary Vitamin D and DID NOT measure Serum Vitamin D level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 163)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 73, 'respiratory'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('UBERON_0001977', 'blood serum', 179, 'serum'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]	0	['however,   diseases interventional supplementary  measure serum  level.']
S115-PMC4889866	PMC4889866	5/2016	S115-PMC4889866	['DEMONSTRATED an ASSOCIATION between low Cord Blood Vitamin D level and increased Respiratory syncytial Virus infections in infancy, HOWEVER, UNLIKE our participants, around 50% of their neonates were Vitamin D sufficient [27–29].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('ANOMALY_CURIOUS_FINDING', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141)]	5	[('UBERON_0002240', 'spinal cord', 40, 'cord'), ('UBERON_0000178', 'blood', 45, 'blood'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 81, 'respiratory'), ('NCBITaxon_1', 'root', 103, 'virus'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]	0	['demonstrated cord blood   syncytial virus infections infancy, however, participants, 50% neonates  [27–29].']
S117-PMC4889866	PMC4889866	5/2016	S117-PMC4889866	['NONETHELESS, in SUPPORT of our results, SEVERAL STUDIES also FAILED to show a difference in Serum Vitamin D level between children with and without Respiratory infections [30–32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61)]	4	[('UBERON_0001977', 'blood serum', 92, 'serum'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 148, 'respiratory')]	0	['nonetheless, results, serum  children  infections [30–32].']
S6211-PMC4896250	PMC4896250	4/2016	S6211-PMC4896250	['a438 Vitamin D level and the CORRELATION with Ige in children with allergic Respiratory diseases in guangzhou china\n\nhuimin huang1, baoqing sun2, yun chen3, peiyan zheng2, nili wei1, wenting luo4\n\n1the first affiliated hospital of guangzhou medical university, china;2first affiliated hospital guangzhou medical university;3guangzhou yuexiu district maternal and child health care hospital;4first affiliated hospital of guangzhou medical university, guangzhou institute of respiratory diseases\n\ncorrespondence: huimin huang – the first affiliated hospital of guangzhou medical university, china\nobjective: TO EXPLORE the Vitamin D(vit D) level and analyse the CORRELATION with Immunoglobulin e (Ige) in children with allergic Respiratory diseases in guangzhou china.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 606), ('SUPERFICIAL_RELATIONSHIP', 660)]	3	[('CHEBI_28384', 'vitamin K', 5, 'Vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 46, 'IgE'), ('UBERON_0001004', 'respiratory system', 76, 'Respiratory'), ('CHEBI_27300', 'vitamin D', 621, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 635, 'D'), ('GO_0019814', 'immunoglobulin complex', 677, 'immunoglobulin'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 695, 'IgE'), ('UBERON_0001004', 'respiratory system', 726, 'respiratory')]	0	['a438 vitamin ige children allergic  diseases guangzhou china\n\nhuimin huang1, baoqing sun2, yun chen3, peiyan zheng2, nili wei1, wenting luo4\n\n1the affiliated hospital guangzhou medical university, china;2first affiliated hospital guangzhou medical university;3guangzhou yuexiu district maternal child hospital;4first affiliated hospital guangzhou medical university, guangzhou institute respiratory diseases\n\ncorrespondence: huimin huang affiliated hospital guangzhou medical university, china\nobjective: (vit d) analyse immunoglobulin e (ige) children allergic  diseases guangzhou china.']
S6217-PMC4896250	PMC4896250	4/2016	S6217-PMC4896250	['using multivariate linear regression analysis after adjusted with sex and age,there is significant ASSOCIATION between the total Ige and Serum Vitamin D (b -4.386, 95%ci -8.488- -0.285, p =0.037) in 40 children with allergic Respiratory diseases, and also significant ASSOCIATION between both total and dp specific Ige and Serum Vitamin D (b -9.56, 95%ci -15.405- -3.715, p =0.003; b -0.857, 95%ci -1.561- -0.153, p =0.02, respectively) in 21 children with dp sensitization.']	[('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 268)]	2	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 129, 'IgE'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 225, 'respiratory'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 315, 'IgE'), ('UBERON_0001977', 'blood serum', 323, 'serum'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D')]	0	['using multivariate linear regression adjusted sex age,there ige serum  (b -4.386, 95%ci -8.488- -0.285, p =0.037) 40 children allergic  diseases, dp ige serum  (b -9.56, 95%ci -15.405- -3.715, p =0.003; b -0.857, 95%ci -1.561- -0.153, p =0.02, respectively) 21 children dp sensitization.']
S117-PMC4897157	PMC4897157	5/2016	S117-PMC4897157	['in a Birth cohort study cord Blood 25(Oh)-Vitamin D deficiency was ASSOCIATED with INCREASED RISK of recurrent troublesome Lung symptoms till age 7 years, BUT SHOWED no association with Respiratory infection, asthma, or rhinitis21).']	[('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 83), ('ANOMALY_CURIOUS_FINDING', 155), ('INCOMPLETE_EVIDENCE', 159)]	4	[('GO_0007567', 'parturition', 5, 'birth'), ('UBERON_0000178', 'blood', 29, 'blood'), ('CHEBI_63056', 'zinc cation', 35, '25(OH'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002048', 'lung', 123, 'lung'), ('UBERON_0001004', 'respiratory system', 186, 'respiratory')]	0	['birth cord blood 25(oh)- recurrent lung symptoms till age 7 years,  infection, asthma, rhinitis21).']
S132-PMC4934634	PMC4934634	11/2015	S132-PMC4934634	['WHILE Vitamin D supplementation to women with Gestational diabetes improved Metabolic parameters, what IS NEEDED are clinical trials investigating the extent to WHICH Vitamin D supplementation decreases adverse Perinatal outcomes ASSOCIATED with Gestational diabetes including macrosomia, Respiratory distress, and Postnatal hypoglycemia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 103), ('EXPLICIT_QUESTION', 161), ('SUPERFICIAL_RELATIONSHIP', 230)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'gestational'), ('GO_0008152', 'metabolic process', 76, 'metabolic'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('GO_0036268', 'swimming', 211, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 211, 'perinatal'), ('GO_0007565', 'female pregnancy', 246, 'gestational'), ('UBERON_0001004', 'respiratory system', 289, 'respiratory'), ('GO_0007567', 'parturition', 315, 'postnatal')]	0	[' supplementation women gestational diabetes metabolic parameters,  supplementation decreases perinatal outcomes gestational diabetes macrosomia,  distress, postnatal hypoglycemia.']
S182-PMC4934634	PMC4934634	11/2015	S182-PMC4934634	['Respiratory health and allergic disease in children\nover the last decade, there is CONFLICTING data on the ROLE of maternal Vitamin D on offspring allergic outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('SUPERFICIAL_RELATIONSHIP', 107)]	2	[('UBERON_0001004', 'respiratory system', 0, 'Respiratory'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]	0	[' allergic disease children\nover last decade, maternal  offspring allergic outcomes.']
S192-PMC4934634	PMC4934634	11/2015	S192-PMC4934634	['one randomized controlled trial INVESTIGATED the EFFECTS of Prenatal Vitamin D supplementation on Respiratory outcomes in children at three years of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('GO_0007565', 'female pregnancy', 60, 'prenatal'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 98, 'respiratory')]	0	['one prenatal  supplementation  outcomes children three age.']
S201-PMC4934634	PMC4934634	11/2015	S201-PMC4934634	['children will be followed for three years for Respiratory health outcomes and the data will provide a better look into the EFFECTS of a higher dose Vitamin D supplement on allergic outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 123)]	1	[('UBERON_0001004', 'respiratory system', 46, 'respiratory'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]	0	['children followed three  outcomes higher dose  supplement allergic outcomes.']
S212-PMC4934634	PMC4934634	11/2015	S212-PMC4934634	['SINCE THE study LOOKED AT the number of visits RATHER than confirmed diagnosis of infection, THIS STUDY SUGGESTS infant Vitamin D supplementation in addition to Prenatal supplementation MIGHT be BENEFICIAL in reducing health care visits for acute Respiratory infections.']	[('PROBLEM_COMPLICATION', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 93), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 186), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'prenatal'), ('UBERON_0001004', 'respiratory system', 247, 'respiratory')]	0	['since visits diagnosis infection, infant  supplementation addition prenatal supplementation reducing visits acute  infections.']
S15-PMC4997421	PMC4997421	8/2016	S15-PMC4997421	['maternal Vitamin A deficiency also has SERIOUS repercussions for the newborn and is ASSOCIATED with depressed Immune function and higher morbidity and mortality due to infections [1], low Birth weight [6], Diaphragmatic hernia [7], bronchopulmonary dysplasia and other Respiratory disease [8,9,10].']	[('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 84)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('UBERON_0002405', 'immune system', 110, 'immune'), ('GO_0007567', 'parturition', 188, 'birth'), ('UBERON_0001103', 'diaphragm', 206, 'diaphragmatic'), ('UBERON_0001004', 'respiratory system', 269, 'respiratory')]	0	['maternal  newborn depressed immune higher morbidity mortality infections [1], birth [6], diaphragmatic hernia [7], bronchopulmonary dysplasia  disease [8,9,10].']
S13-PMC5045784	PMC5045784	10/2016	S13-PMC5045784	['introduction\nbronchopulmonary dysplasia (bpd) is the MOST PREVALENT long-term morbidity among surviving EXTREMELY preterm infants and has a MULTIFACTORIAL etiology.1bpd is ASSOCIATED with later risk of reactive Airways disease, such as asthma,2post neonatal mortality and adverse Neurodevelopmental outcomes.1bpd AFFECTS ~20% of preterm infants, and up to 60% of extremely preterm infants who are Born before 26 completed weeks of Gestation.2an ESTIMATED 10\u2009000 to 15\u2009000 infants are affected in the united states each year and this has substantial medical and socioeconomic IMPLICATIONS.2,3\nACCUMULATING epidemiologic EVIDENCE SUGGESTS that Vitamin D deficiency or insufficiency is ASSOCIATED with Respiratory disease in children.']	[('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 104), ('DIFFICULT_TASK', 140), ('SUPERFICIAL_RELATIONSHIP', 172), ('SUPERFICIAL_RELATIONSHIP', 313), ('INCOMPLETE_EVIDENCE', 445), ('IMPORTANT_CONSIDERATION', 575), ('INCOMPLETE_EVIDENCE', 592), ('INCOMPLETE_EVIDENCE', 628), ('SUPERFICIAL_RELATIONSHIP', 683)]	10	[('UBERON_0001005', 'respiratory airway', 211, 'airways'), ('GO_0007399', 'nervous system development', 280, 'neurodevelopmental'), ('GO_0007567', 'parturition', 397, 'born'), ('GO_0007565', 'female pregnancy', 431, 'gestation'), ('CHEBI_27300', 'vitamin D', 642, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 699, 'respiratory')]	0	['introduction\nbronchopulmonary dysplasia (bpd) long-term morbidity among surviving preterm infants etiology.1bpd reactive airways disease, asthma,2post neonatal mortality neurodevelopmental outcomes.1bpd ~20% preterm infants, 60% preterm infants born 26 completed weeks gestation.2an 10\u2009000 15\u2009000 infants united year medical socioeconomic implications.2,3\naccumulating epidemiologic   disease children.']
S58-PMC5045784	PMC5045784	10/2016	S58-PMC5045784	"['[""""our study is IN AGREEMENT with a study by onwuneme et al.16in which, in a cohort of 94 preterm infants (<32 weeks\' Gestation), there was no association with bpd or other morbidities of Prematurity although the authors FOUND an ASSOCIATION between Vitamin D status and acute Respiratory morbidity (AS defined by differences in duration of positive pressure ventilation and highest oxygen concentration required in the delivery room and the odds of requiring assisted ventilation).""""]']"	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 218), ('SUPERFICIAL_RELATIONSHIP', 227), ('PROBABLE_UNDERSTANDING', 297)]	4	[('GO_0007565', 'female pregnancy', 115, 'gestation'), ('GO_0007565', 'female pregnancy', 185, 'prematurity'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 274, 'respiratory')]	0	"['[""""our study onwuneme et al.16in which, 94 preterm infants (<32 weeks* gestation), bpd morbidities prematurity authors betwen status acuory morbidity (as duration positive pressure ventilation oxygen concentration delivery ventilation).""""]']"
S59-PMC5045784	PMC5045784	10/2016	S59-PMC5045784	['SIMILARLY, a RECENT interventional TRIAL of three dosing regimens for Vitamin D supplementation in extremely preterm infants FOUND no association between Vitamin D status and Respiratory outcomes.17\nthe IMPORTANCE of Vitamin D status in pediatric Respiratory health is SUPPORTED by large epidemiologic studies of term infants SHOWING an ASSOCIATION between suboptimal Vitamin D status and wheezing.4,18in addition, Animal studies demonstrate an IMPORTANT biologic ROLE for Vitamin D in Lung Development and Maturation, including Differentiation Of Type Ii Pneumocytes, Surfactant Phospholipid synthesis and secretion,19as well as an immunomodulatory ROLE in Epithelial Cells, Neutrophils and Macrophages.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 125), ('IMPORTANT_CONSIDERATION', 203), ('INCOMPLETE_EVIDENCE', 269), ('INCOMPLETE_EVIDENCE', 326), ('SUPERFICIAL_RELATIONSHIP', 337), ('IMPORTANT_CONSIDERATION', 445), ('SUPERFICIAL_RELATIONSHIP', 464), ('SUPERFICIAL_RELATIONSHIP', 650)]	10	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 175, 'respiratory'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 247, 'respiratory'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 415, 'animal'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D'), ('GO_0035180', 'larval wandering behavior', 486, 'lung development ... maturation'), ('UBERON_0002048', 'lung', 486, 'lung'), ('GO_0007620', 'copulation', 529, 'differentiation of ...'), ('CL_0002063', 'type II pneumocyte', 548, 'type II pneumocytes'), ('CHEBI_53015', 'N(6)-carboxymethyl-L-lysine residue', 569, 'surfactant phospholipid'), ('CL_0000066', 'epithelial cell', 658, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 658, 'epithelial'), ('CL_0000775', 'neutrophil', 676, 'neutrophils'), ('CL_0000235', 'macrophage', 692, 'macrophages')]	0	['similarly, three dosing regimens  supplementation preterm infants  status  outcomes.17\nthe  status pediatric  epidemiologic term infants  status wheezing.4,18in addition, animal biologic  lung maturation, type ii pneumocytes, surfactant phospholipid synthesis secretion,19as immunomodulatory epithelial cells, neutrophils macrophages.']
S67-PMC5045784	PMC5045784	10/2016	S67-PMC5045784	['the ASSOCIATION between low Vitamin D levels and Respiratory morbidity as SEEN in older children and Adults MAY BE DUE TO DIFFERENT pathology than that SEEN in bpd, which is characterized by Alveolar simplification and impaired septation.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('INCOMPLETE_EVIDENCE', 152)]	6	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 49, 'respiratory'), ('UBERON_0007023', 'adult organism', 101, 'adults'), ('UBERON_0003215', 'alveolus', 191, 'alveolar')]	0	[' levels  morbidity older children adults pathology bpd, alveolar simplification septation.']
S0-PMC5064894	PMC5064894	10/2016	S0-PMC5064894	['maternal Vitamin D supplementation during Pregnancy and Lactation to prevent acute Respiratory infections in infancy in dhaka, bangladesh (mdari trial): protocol for a prospective cohort study nested within a randomized controlled trial\n\nabstract\n\nbackground\nearly Infancy is a HIGH-RISK period for SEVERE acute Respiratory infection (ari), PARTICULARLY in low-income countries with resource-limited Health Systems.']	[('IMPORTANT_CONSIDERATION', 278), ('IMPORTANT_CONSIDERATION', 299), ('IMPORTANT_CONSIDERATION', 341)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0007595', 'lactation', 56, 'lactation'), ('UBERON_0001004', 'respiratory system', 83, 'respiratory'), ('UBERON_0000023', 'wing', 265, 'infancy'), ('UBERON_0001004', 'respiratory system', 312, 'respiratory'), ('UBERON_0002423', 'hepatobiliary system', 400, 'health systems')]	0	['maternal  supplementation pregnancy lactation acute  infections infancy dhaka, bangladesh (mdari trial): protocol trial\n\nabstract\n\nbackground\nearly infancy period acute  infection (ari), low-income countries resource-limited systems.']
S37-PMC5064894	PMC5064894	10/2016	S37-PMC5064894	['first, THERE HAVE BEEN NO STUDIES examining the EFFECT of Prenatal Vitamin D supplementation on a primary outcome of laboratory-confirmed Viral Respiratory infections in the first 6\xa0months of Life, a high-risk period for both Vitamin D deficiency and Respiratory Tract infections.']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 48)]	4	[('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('NCBITaxon_1', 'root', 138, 'viral'), ('UBERON_0001004', 'respiratory system', 144, 'respiratory'), ('UBERON_0000104', 'life cycle', 192, 'life'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 251, 'respiratory tract')]	0	['first, prenatal  supplementation outcome laboratory-confirmed viral  infections 6\xa0months life, period  respiratory tract infections.']
S168-PMC5064894	PMC5064894	10/2016	S168-PMC5064894	['we thus maintain 80\xa0% power to address the QUESTION of WHETHER maternal Vitamin D supplementation CAN reduce the rate of microbiologically-confirmed acute Respiratory infections, while simultaneously being able to address WHETHER lower doses are also EFFECTIVE, and TO INVESTIGATE WHETHER a dose–response RELATIONSHIP exists, thereby SUPPORTING the biological PLAUSIBILITY and robustness of inferences.']	[('EXPLICIT_QUESTION', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 55), ('EXPLICIT_QUESTION', 55), ('INCOMPLETE_EVIDENCE', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 222), ('SUPERFICIAL_RELATIONSHIP', 251), ('QUESTION_ANSWERED_BY_THIS_WORK', 266), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('SUPERFICIAL_RELATIONSHIP', 305), ('INCOMPLETE_EVIDENCE', 334), ('INCOMPLETE_EVIDENCE', 360)]	11	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 155, 'respiratory')]	0	['maintain 80\xa0% maternal  supplementation rate microbiologically-confirmed acute  infections, able doses effective, dose–response exists, biological inferences.']
S193-PMC5064894	PMC5064894	10/2016	S193-PMC5064894	['discussion\nthe mdari study in dhaka, bangladesh leverages the infrastructure of a large randomized placebo controlled, dose-ranging trial of maternal Vitamin D supplementation during Pregnancy and Lactation in bangladesh TO TEST the HYPOTHESIS that maternal Vitamin D supplementation CAN decrease infant Respiratory infections during the HIGH RISK first 6\xa0months of infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 221), ('INCOMPLETE_EVIDENCE', 233), ('INCOMPLETE_EVIDENCE', 284), ('IMPORTANT_CONSIDERATION', 338)]	4	[('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'pregnancy'), ('GO_0007595', 'lactation', 197, 'lactation'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 304, 'respiratory')]	0	['discussion\nthe mdari dhaka, bangladesh leverages infrastructure placebo controlled, dose-ranging maternal  supplementation pregnancy lactation bangladesh maternal  supplementation decrease infant  infections 6\xa0months infancy.']
S130-PMC5084016	PMC5084016	10/2016	S130-PMC5084016	['low Birth weight, impaired Skeletal Development, and Respiratory infections and allergic diseases in the early years of Life are OFTEN ASSOCIATED with INADEQUATE CONTRIBUTION of Vitamin D from the mother’s diet.']	[('PROBABLE_UNDERSTANDING', 129), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 151), ('SUPERFICIAL_RELATIONSHIP', 162)]	4	[('GO_0007567', 'parturition', 4, 'birth'), ('GO_0001501', 'skeletal system development', 27, 'skeletal development'), ('UBERON_0004288', 'skeleton', 27, 'skeletal'), ('UBERON_0001004', 'respiratory system', 53, 'respiratory'), ('UBERON_0000104', 'life cycle', 120, 'life'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]	0	['low birth weight, skeletal development,  infections allergic diseases life  mother’s diet.']
S4-PMC5129897	PMC5129897	10/2016	S4-PMC5129897	['we used 25(Oh)D concentration–health outcome RELATIONS for Breast cancer and Cardiovascular disease and results of clinical trials with Vitamin D for Respiratory infections and Musculoskeletal disorders to ESTIMATE the reductions in disease BURDEN for increased 25(Oh)D concentrations.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 206), ('IMPORTANT_CONSIDERATION', 241)]	3	[('CHEBI_71657', 'versiconol acetate', 8, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 14, 'D'), ('UBERON_0000310', 'breast', 59, 'breast'), ('UBERON_0004535', 'cardiovascular system', 77, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 150, 'respiratory'), ('UBERON_0002204', 'musculoskeletal system', 177, 'musculoskeletal'), ('CHEBI_71657', 'versiconol acetate', 262, '25(OH)D')]	0	['25(oh)d concentration–health outcome breast cancer cardiovascular disease results   infections musculoskeletal disorders reductions disease 25(oh)d concentrations.']
S27-PMC5129897	PMC5129897	10/2016	S27-PMC5129897	['materials and methods\npublications on the RELATIONS between 25(Oh)D concentrations and health outcomes were obtained LARGELY by searchingpubmed.govandscholar.google.comfor terms such as Vitamin D, 25-Hydroxyvitamin D, meta-analysis, Back and Spine disorders, cancer, Cardiovascular disease, Immune System, osteoporosis, Respiratory infection, economic BURDEN, canada, cost, season, mortality, incidence , and risk .']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 352)]	3	[('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 60, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 197, '25-hydroxyvitamin D'), ('UBERON_0001137', 'dorsum', 233, 'back'), ('UBERON_0001013', 'adipose tissue', 242, 'spine'), ('UBERON_0004535', 'cardiovascular system', 267, 'cardiovascular'), ('UBERON_0002405', 'immune system', 291, 'immune system'), ('UBERON_0001004', 'respiratory system', 320, 'respiratory')]	0	['materials methods\npublications 25(oh)d concentrations outcomes searchingpubmed.govandscholar.google.comfor terms 25-hydroxyvitamin d, meta-analysis, back spine disorders, cancer, cardiovascular disease, immune system, osteoporosis,  infection, economic burden, canada, cost, season, mortality, .']
S74-PMC5129897	PMC5129897	10/2016	S74-PMC5129897	"['[""""based on data from the us for 2004–2013, using the national cancer institute\'s surveillance, epidemiology, and end results (seer) program, cancer incidence rates for those aged 20–49\\xa0y is 2% of that for those aged >50\\xa0y.53\\n\\nrespiratory infections\\ninfluenza and pneumonia accounted for 5,694 deaths of canadians in 2012.54the total economic impact for Respiratory infections was $5.4\\xa0billion in 2008.55the ESTIMATED economic BURDEN in 2016 is$5.4\\xa0billion\\u2009×\\u2009(1.033)2\\u2009×\\u2009(0.994)6\\u2009×\\u2009(36.3\\xa0million/33.3\\xa0million)\\xa0=\\xa0$6.1\\xa0billion\\nclinical trials SUPPORT the ROLE of Vitamin D in reducing RISK of influenza.""""]']"	[('INCOMPLETE_EVIDENCE', 405), ('IMPORTANT_CONSIDERATION', 424), ('INCOMPLETE_EVIDENCE', 537), ('SUPERFICIAL_RELATIONSHIP', 549), ('IMPORTANT_CONSIDERATION', 579)]	5	[('UBERON_0001004', 'respiratory system', 351, 'respiratory'), ('CHEBI_27300', 'vitamin D', 557, 'vitamin D')]	0	"['[""""based us 2004–2013, using national cancer institute*s surveillance, epidemiology, results (seer) program, cancer rates aged 20–49\\xa0y 2% aged >50\\xa0y.53\\n\\nrespiratory infections\\ninfluenza pneumonia 5,694 deaths canadians 2012.54the economic respiratory infections $5.4\\xa0billion 2008.55the economic 2016 is$5.4\\xa0billion\\u2009×\\u2009(1.033)2\\u2009×\\u2009(0.994)6\\u2009×\\u2009(36.3\\xa0million/33.3\\xa0millioa0$6.1\\xa0billion\\nclinical vitamin reducing influenza.""""]']"
S118-PMC5129897	PMC5129897	10/2016	S118-PMC5129897	"['[""""“the CURRENTLY AVAILABLE results INDICATE that Vitamin D supplementation during Pregnancy reduces the RISK of Preterm Birth, low Birth weight, Dental caries of infancy, and neonatal infectious diseases such as Respiratory infections and sepsis.”81furthermore, with UNFOLDING RESEARCH into fetal origins of pediatric and Adult disease, EVIDENCE increasingly INDICATES that Gestational Vitamin D indices MAY determine health in later Life.82for example, an INTERESTING cohort study CORRELATING maternal Vitamin D levels at 18\\xa0weeks\' Pregnancy and health outcomes of progeny FOUND that Gestational Vitamin D deficiency was ASSOCIATED with a higher risk of impaired Lung Development in 6-year-old offspring, Neurocognitive difficulties at age 10\\xa0years, increased risk of Eating disorders in Adolescence, and lower peak bone mass at 20\\xa0y.83\\na RECENT STUDY CONCLUDED that Vitamin D is reduces exacerbations of asthma.84\\n\\nall-cause mortality rate\\ngarland and colleagues85presented a meta-analysis of 32 prospective observational studies that investigated all-cause mortality rate with respect to 25(Oh)D concentration at time of enrollment.""""]']"	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 33), ('IMPORTANT_CONSIDERATION', 102), ('INCOMPLETE_EVIDENCE', 265), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 402), ('ANOMALY_CURIOUS_FINDING', 455), ('SUPERFICIAL_RELATIONSHIP', 480), ('INCOMPLETE_EVIDENCE', 572), ('SUPERFICIAL_RELATIONSHIP', 620), ('INCOMPLETE_EVIDENCE', 838), ('INCOMPLETE_EVIDENCE', 851)]	13	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'preterm'), ('GO_0007567', 'parturition', 118, 'birth'), ('GO_0007567', 'parturition', 129, 'birth'), ('UBERON_0001091', 'calcareous tooth', 143, 'dental'), ('UBERON_0001004', 'respiratory system', 210, 'respiratory'), ('UBERON_0007023', 'adult organism', 320, 'adult'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('UBERON_0000104', 'life cycle', 432, 'life'), ('CHEBI_27300', 'vitamin D', 501, 'vitamin D'), ('GO_0007565', 'female pregnancy', 531, 'pregnancy'), ('GO_0007565', 'female pregnancy', 583, 'gestational'), ('CHEBI_27300', 'vitamin D', 595, 'vitamin D'), ('GO_0030324', 'lung development', 662, 'lung development'), ('UBERON_0002048', 'lung', 662, 'lung'), ('GO_0050905', 'neuromuscular process', 704, 'neurocognitive'), ('GO_0051318', 'G1 phase', 767, 'eating'), ('GO_0048848', 'neurohypophysis morphogenesis', 787, 'adolescence'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1089, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1089, '25(OH ... D')]	0	"['[""""“the results thn supplementation pregnancy reduces preterm birth, birth weight, dental caries infancy, neonatal infectious diseases ory infections sepsis.”81furthermore, fetal origins pediatric adult disease, gestationn indices life.82for example, maternn levels 18\\xa0weeks* pregnancy outcomes progeny gestatamin higher lung 6-year-old offspring, neurocognitive age 10\\xa0years, eating disorders adolescence, peak bone mass 20\\xa0y.83\\na cohat vitamin reduces exacerbations asthma.84\\n\\nall-cause mortality rate\\ngarland colleagues85presented meta-analysis 32 all-cause mortality rate respect 25(oh)d concentration enrollment.""""]']"
S0-PMC5340372	PMC5340372	3/2017	S0-PMC5340372	['low Cord-Serum 25-Hydroxyvitamin D levels are ASSOCIATED with poor Lung function performance and increased Respiratory infection in infancy\n\nabstract\n\nbackground\nPerinatal Vitamin D deficiency is ASSOCIATED with a higher RISK of wheezing in childhood.']	[('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 196), ('IMPORTANT_CONSIDERATION', 221)]	3	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 15, '25-hydroxyvitamin D'), ('UBERON_0002048', 'lung', 67, 'lung'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory'), ('GO_0036268', 'swimming', 162, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 162, 'Perinatal'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]	0	['low cord-serum 25-hydroxyvitamin levels lung performance  infection infancy\n\nabstract\n\nbackground\nperinatal  higher wheezing childhood.']
S2-PMC5340372	PMC5340372	3/2017	S2-PMC5340372	['the AIM of THIS STUDY was TO INVESTIGATE the IMPACT of Perinatal Vitamin D levels on Respiratory function and disease outcome in infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('GO_0036268', 'swimming', 55, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 55, 'perinatal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 85, 'respiratory')]	0	['perinatal  levels  disease outcome infancy.']
S10-PMC5340372	PMC5340372	3/2017	S10-PMC5340372	['conclusion\nalthough a high CORRELATION was FOUND between maternal and Cord Vitamin D levels, the EFFECT on Respiratory outcome was DIFFERENT.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131)]	4	[('UBERON_0002240', 'spinal cord', 70, 'cord'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory')]	0	['conclusion\nalthough maternal cord  levels,  outcome different.']
S25-PMC5340372	PMC5340372	3/2017	S25-PMC5340372	['HOWEVER, the RELATIONSHIP between Vitamin D levels and Respiratory function during infancy has NOT YET been clarified.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 95)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 55, 'respiratory')]	0	['however,  levels  infancy clarified.']
S26-PMC5340372	PMC5340372	3/2017	S26-PMC5340372	['the primary PURPOSE of this study was TO INVESTIGATE the EFFECT of Perinatal Vitamin D levels on the performance of Respiratory function in infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('GO_0036268', 'swimming', 67, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 67, 'perinatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 116, 'respiratory')]	0	['perinatal  levels performance  infancy.']
S144-PMC5340372	PMC5340372	3/2017	S144-PMC5340372	['ALTHOUGH poor Lung function performance and an INCREASED RISK of Respiratory Tract infection were RELATED to relatively low cord Serum Vitamin D levels, FURTHER extrapolating the EFFECTS of Vitamin d on the Respiratory function of the general infant population MIGHT STILL BE DIFFICULT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 153), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 261), ('FUTURE_WORK', 267), ('DIFFICULT_TASK', 276)]	8	[('UBERON_0002048', 'lung', 14, 'lung'), ('UBERON_0000065', 'respiratory tract', 65, 'respiratory tract'), ('UBERON_0001977', 'blood serum', 129, 'serum'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 190, 'vitamin'), ('UBERON_0001004', 'respiratory system', 207, 'respiratory')]	0	['although lung performance respiratory tract infection cord serum  levels, vitamin  infant population difficult.']
S147-PMC5340372	PMC5340372	3/2017	S147-PMC5340372	['ALTHOUGH Cord Vitamin D levels are STRONGLY CORRELATED with maternal Vitamin D levels, the extent of the IMPACT on later Respiratory function is DISTINCTIVE.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 35), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 145)]	5	[('UBERON_0002240', 'spinal cord', 9, 'cord'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0045333', 'cellular respiration', 121, 'respiratory'), ('UBERON_0001004', 'respiratory system', 121, 'respiratory')]	0	['although cord  levels maternal  levels,  distinctive.']
S148-PMC5340372	PMC5340372	3/2017	S148-PMC5340372	['we BELIEVE that THIS STUDY PROVIDES a CLEARER UNDERSTANDING of the EFFECT of Perinatal Vitamin D levels on Respiratory function and Respiratory outcome in infancy.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('PROBABLE_UNDERSTANDING', 27), ('PROBABLE_UNDERSTANDING', 38), ('SUPERFICIAL_RELATIONSHIP', 67)]	5	[('GO_0036268', 'swimming', 77, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 77, 'perinatal'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory'), ('UBERON_0001004', 'respiratory system', 132, 'respiratory')]	0	['perinatal  levels   outcome infancy.']
S28-PMC5634602	PMC5634602	10/2017	S28-PMC5634602	['another trial evaluating placebo, 200 iu and 800 iu daily Vitamin D supplement evaluated levels at 36 weeks and days of Respiratory support, SHOWING PREVENTION of Vitamin D deficiency with the 800 iu dose, and an improvement in Serum levels with the 200 iu dose as compared to placebo, but no difference in days alive or in Respiratory support [11].']	[('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 149)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 120, 'respiratory'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('UBERON_0001977', 'blood serum', 228, 'serum'), ('UBERON_0001004', 'respiratory system', 324, 'respiratory')]	0	['another placebo, 200 iu 800 iu daily  supplement levels 36 weeks days  support,  800 iu dose, serum levels 200 iu dose placebo, days alive  [11].']
S30-PMC5634602	PMC5634602	10/2017	S30-PMC5634602	['as the ROLE of Vitamin D in Immune function, Respiratory health, allergy and atopic disease, and many other Tissue and Organ functions becomes apparent, adjustments have BEEN SUGGESTED in OPTIMAL Serum level of 25(Oh)D [12–14].']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 170), ('IMPORTANT_CONSIDERATION', 188)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0002405', 'immune system', 28, 'immune'), ('UBERON_0001004', 'respiratory system', 45, 'respiratory'), ('UBERON_0000479', 'tissue', 108, 'tissue'), ('UBERON_0000062', 'organ', 119, 'organ'), ('UBERON_0001977', 'blood serum', 196, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 217, 'D')]	0	[' immune function,  health, allergy atopic disease, tissue organ functions becomes apparent, serum 25(oh)d [12–14].']
S139-PMC5941617	PMC5941617	5/2018	S139-PMC5941617	['in addition to optimize bone mineralization during fetal Life, Vitamin D status HAS BEEN ASSOCIATED with acute Respiratory morbidity in preterm infants Born <\u200932\xa0weeks Gestation [124].']	[('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 89)]	2	[('UBERON_0000104', 'life cycle', 57, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 111, 'respiratory'), ('GO_0007567', 'parturition', 152, 'born'), ('GO_0007565', 'female pregnancy', 168, 'gestation')]	0	['addition optimize bone mineralization fetal life,  status acute  morbidity preterm infants born <\u200932\xa0weeks gestation [124].']
S285-PMC5941617	PMC5941617	5/2018	S285-PMC5941617	['a RELATIONSHIP between Vitamin D status and the incidence or the severity of Respiratory infections in children HAS BEEN FOUND in MANY observational STUDIES, most with a case-control or cross sectional design, both in developing and in westernized countries.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 130)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 77, 'respiratory')]	0	[' status  infections children studies, case-control design, westernized countries.']
S287-PMC5941617	PMC5941617	5/2018	S287-PMC5941617	['the LINK between SEVERE Vitamin D deficiency and susceptibility to Respiratory infections is prototypically represented by the high Respiratory morbidity in children with rickets [243,244].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 17)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 67, 'respiratory'), ('UBERON_0001004', 'respiratory system', 132, 'respiratory')]	0	['  infections prototypically  morbidity children rickets [243,244].']
S291-PMC5941617	PMC5941617	5/2018	S291-PMC5941617	['OBVIOUSLY, the more ROBUST EVIDENCES on the ASSOCIATION between Vitamin D deficiency and Respiratory infections stem from prospective studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 89, 'respiratory')]	0	['obviously,   infections stem studies.']
S292-PMC5941617	PMC5941617	5/2018	S292-PMC5941617	['camargo et al., after adjusting for season of Birth, FOUND that newborns with Vitamin D Cord Blood levels <\u200910\xa0ng/ml had a two-fold (odds ratio: 2.16; 95% ci 1.35–3.46) increased risk of Respiratory infections by 3\xa0months of age as COMPARED TO newborns with 25(Oh)D concentrations >\u200930\xa0ng/ml [252].']	[('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232)]	2	[('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('UBERON_0001004', 'respiratory system', 187, 'respiratory'), ('CHEBI_71657', 'versiconol acetate', 258, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 258, '25(OH)D')]	0	['camargo et al., adjusting season birth, newborns  cord blood levels <\u200910\xa0ng/ml two-fold (odds ratio: 2.16; 95% ci 1.35–3.46)  infections 3\xa0months age newborns 25(oh)d concentrations >\u200930\xa0ng/ml [252].']
S294-PMC5941617	PMC5941617	5/2018	S294-PMC5941617	['also DEMONSTRATED that Cord Blood Vitamin D levels <\u200920\xa0ng/ml were ASSOCIATED with a sixfold (95% ci: 1.6–24.9) increased risk of Respiratory syncytial Virus lower Respiratory Tract infections in the first year of Life as compared with concentrations ≥30\xa0ng/ml [249].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('UBERON_0002240', 'spinal cord', 23, 'cord'), ('UBERON_0000178', 'blood', 28, 'blood'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 130, 'respiratory'), ('NCBITaxon_1', 'root', 152, 'virus'), ('UBERON_0000065', 'respiratory tract', 164, 'respiratory tract'), ('UBERON_0000104', 'life cycle', 214, 'life')]	0	['also cord blood  levels <\u200920\xa0ng/ml sixfold (95% ci: 1.6–24.9)  syncytial virus respiratory tract infections year life concentrations ≥30\xa0ng/ml [249].']
S297-PMC5941617	PMC5941617	5/2018	S297-PMC5941617	['OTHER STUDIES have FOUND an inverse ASSOCIATION between Vitamin D concentrations in Pregnancy and the RISK of Respiratory infections in newborns or children during the first 3\xa0years of life [253,254].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 36), ('IMPORTANT_CONSIDERATION', 102)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('UBERON_0001004', 'respiratory system', 110, 'respiratory')]	0	[' concentrations pregnancy  infections newborns children 3\xa0years life [253,254].']
S300-PMC5941617	PMC5941617	5/2018	S300-PMC5941617	['taken TOGETHER, all these data INDICATE that Vitamin D status MIGHT have SOME INFLUENCE on conditioning the incidence and severity of SOME but not all type of Respiratory infections and that more information are REQUIRED before drawing any firm conclusion on THIS topic.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 134), ('FUTURE_WORK', 212), ('IMPORTANT_CONSIDERATION', 212), ('QUESTION_ANSWERED_BY_THIS_WORK', 259)]	9	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 159, 'respiratory')]	0	['taken together,  status conditioning type  infections drawing topic.']
S302-PMC5941617	PMC5941617	5/2018	S302-PMC5941617	['furthermore, SOME ROLE from vdr polymorphisms or OTHER Genetic factors MIGHT play a ROLE in determining the INFLUENCE of Vitamin D status on Respiratory morbidity [257,258].']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 84), ('SUPERFICIAL_RELATIONSHIP', 108)]	6	[('SO_0000704', 'gene', 55, 'genetic'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 141, 'respiratory')]	0	['furthermore, vdr polymorphisms genetic play  status  morbidity [257,258].']
S303-PMC5941617	PMC5941617	5/2018	S303-PMC5941617	['SEVERAL STUDIES, mostly in Adults, have also addressed the QUESTION WHETHER Vitamin D supplementation CAN PREVENT OR reduce the severity of upper or lower Respiratory infections.']	[('INCOMPLETE_EVIDENCE', 0), ('EXPLICIT_QUESTION', 59), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('EXPLICIT_QUESTION', 68), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	7	[('UBERON_0007023', 'adult organism', 27, 'adults'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 155, 'respiratory')]	0	['several studies, adults,  supplementation upper  infections.']
S306-PMC5941617	PMC5941617	5/2018	S306-PMC5941617	['all BUT two [259,261] of the aforementioned reviews concluded that published studies do not INDICATE a PROTECTIVE EFFECT of Vitamin D supplementation on the PREVENTION of acute Respiratory infections in healthy Individuals.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 157)]	5	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 177, 'respiratory'), ('NCBITaxon_1', 'root', 211, 'individuals')]	0	['[259,261]  supplementation acute  infections healthy individuals.']
S313-PMC5941617	PMC5941617	5/2018	S313-PMC5941617	['finally, LIMITED DATA are available on Vitamin D supplementation in Pregnancy and the RISK of Respiratory infections in the offspring [272,273].']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 86)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('UBERON_0001004', 'respiratory system', 94, 'respiratory')]	0	['finally,  supplementation pregnancy  infections offspring [272,273].']
S663-PMC5941617	PMC5941617	5/2018	S663-PMC5941617	['Extraskeletal actions of Vitamin D\n\nrespiratory infections\n\nRECENT STUDIES SUGGEST an ASSOCIATION between Vitamin D deficiency and the severity or the incidence of Respiratory infections in children.']	[('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('UBERON_0001431', 'distal carpal bone 2', 0, 'Extraskeletal'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 164, 'respiratory')]	0	['extraskeletal \n\nrespiratory infections\n\nrecent   infections children.']
S664-PMC5941617	PMC5941617	5/2018	S664-PMC5941617	['HOWEVER, BECAUSE CURRENT EVIDENCE IS WEAK, we SUGGEST against Vitamin D administration as a therapy for Respiratory infections, beyond the correction of a DOCUMENTED Vitamin D deficiency.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 104, 'respiratory'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]	0	['however, weak,  administration therapy  infections, correction  deficiency.']
S665-PMC5941617	PMC5941617	5/2018	S665-PMC5941617	['NO DEFINITIVE EVIDENCE exists to RECOMMEND Vitamin D supplementation for PREVENTION of Respiratory infections (non-associated with wheezing) or recurrent Respiratory infections.']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 87, 'respiratory'), ('UBERON_0001004', 'respiratory system', 154, 'respiratory')]	0	[' supplementation  infections (non-associated wheezing) recurrent  infections.']
S673-PMC5941617	PMC5941617	5/2018	S673-PMC5941617	['we RECOMMEND against Vitamin D supplementation to reduce incidence or severity of non-Respiratory infections in children.']	[('FUTURE_WORK', 3)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 86, 'respiratory')]	0	[' supplementation non- infections children.']
S15-PMC6043562	PMC6043562	7/2018	S15-PMC6043562	['OTHER STUDIES have FOUND PROTECTIVE ASSOCIATIONS of maternal Antenatal Vitamin D or antioxidant Nutrient intake with later allergic or Respiratory outcomes8–12, THOUGH their findings have NOT always been reproducible13–16.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 161), ('ANOMALY_CURIOUS_FINDING', 161), ('ANOMALY_CURIOUS_FINDING', 188)]	8	[('GO_0007567', 'parturition', 61, 'antenatal'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_33284', 'nutrient', 96, 'nutrient'), ('UBERON_0001004', 'respiratory system', 135, 'respiratory')]	0	['maternal antenatal  antioxidant nutrient intake allergic  outcomes8–12, reproducible13–16.']
